EOS Med Chem Impurity Stock 20201029-13

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

β-Ionylideneacetonitrile-d5, CAS: /, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆D₅N.

1-Amino-4-methylpyridinium Iodide, CAS: 7583-92-8, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉IN₂.

Mouse Abca4 (Retinal-specific ATP-binding cassette transporter) ELISA Kit (96T), CAS: /, stock: 7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

3-Allylrhodanine, CAS: 1457-47-2, stock: 7.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇NOS₂.

Mouse Rgr (RPE-retinal G protein-coupled receptor) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Rlbp1 (Retinaldehyde-binding protein 1) ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

3-​Hexyl-​2-​thioxo-​1,​3-​thiazolidin-​4-​one, CAS: 56347-27-4, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NOS₂.

3-Ethylrhodanine, CAS: 03/01/7648, stock: 4.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇NOS₂.

O-tert-Butyldimethylsilyl 11,12-Didehydro Retinol, CAS: 210700-51-9, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂OSi.

3-Rhodanineacetic Acid, CAS: 5718-83-2, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅NO₃S₂.

rac 11-cis-3-Hydroxy Retinal, CAS: 102918-00-3, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

rac all-trans 3-Hydroxyretinal-d5, CAS: 1185245-26-4, stock: 8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₅O₂.

rac all-trans 4-Hydroxy Retinal, CAS: 18344-42-8, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

rac-all-trans 3-Hydroxy Retinal (80%), CAS: 6890-91-1, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

RTA 408, CAS: 1474034-05-3, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₄F₂N₂O₃.

4-Oxo-5-(3-phenyl-2-propen-1-ylidene)-2-thioxo-3-thiazolidineacetic Acid, CAS: 82158-77-8, stock: 8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₃S₂.

4-Oxo-5-[2-(phenylmethylene)butylidene]-2-thioxo-3-thiazolidineacetic Acid, CAS: 82158-95-0, stock: 8.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₃S₂.

RTA 408-d3, CAS: /, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₁D₃F₂N₂O₃.

SQ 22536, CAS: 17318-31-9, stock: 4.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O.

5-(4-Diethylaminobenzylidene)rhodanine, CAS: 35778-58-6, stock: 7.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂OS₂.

Unoprostane, CAS: 120373-36-6, stock: 3.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₈O₅.

Vitamin A-d5 Acetate, CAS: 1217219-62-9, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇D₅O₂.

Methyl 2-(4-oxo-2-thioxothiazolidin-3-yl)acetate, CAS: 149789-77-5, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇NO₃S₂.

N-Acetamidorhodanine Monohydrate, CAS: 73855-54-6, stock: 4.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O₂S₂ • H ₂O.

WAY 316606 Hydrochloride, CAS: 1781835-02-6, stock: 3.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉F₃N₂O₄S₂ • HCl.

Rhodanine, CAS: 141-84-4, stock: 6.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃NOS₂.

(E)-1-[4-(Trifluoromethyl)phenyl]-2-(3,5-dichlorophenyl)ethene, CAS: 688348-33-6, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉Cl₂F₃.

(E)-3,5,4’-Tribenzyloxystilbene, CAS: 89946-06-5, stock: 4.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₀O₃.

(E)-3,5,4’-Tribenzyloxystilbene-d21, CAS: /, stock: 2.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₉D₂₁O₃.

1,3-Bis(methoxymethoxy)-5-[(1E)-2-[4-(methoxymethoxy)phenyl]ethenyl]-benzene, CAS: 1414361-09-3, stock: 1.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄O₆.

1-(3,5-Diacetoxyphenyl)-1-bromoethane, CAS: 1026420-83-6, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃BrO₄.

1-(3,5-Diacetoxyphenyl)-1-bromoethane-13C6, CAS: /, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₁₃BrO₄.

1-(3,5-Diacetoxyphenyl)-1-ethanol, CAS: 847862-83-3, stock: 3.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₅.

3,5-Diacetoxy Styrene, CAS: 155222-48-3, stock: 6.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₄.

3,5-Dimethoxybenzyl Alcohol, CAS: 705-76-0, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₃.

3,5-Dimethoxyiodobenzene, CAS: 25245-27-6, stock: 3.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉IO₂.

3,5-Dimethoxyphenylmagnesium Chloride, CAS: 89981-17-9, stock: 2.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉ClMgO₂.

3-Acetoxy-5-hydroxy Styrene, CAS: 920489-98-1, stock: 4.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃.

4-Iodophenyl 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: 490028-18-7, stock: 8.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁IO₁₀.

4’-Bromo-resveratrol, CAS: 1224713-90-9, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁BrO₂.

4’-O-Acetyl cis Resveratrol 3-O-β-D-Glucuronide Methyl Ester Triacetate, CAS: /, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₀O₁₃.

5-Iodoresorcinol, CAS: 64339-43-1, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅IO₂.

5-Iodoresorcinol-2’,3’,4’-tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: 490028-20-1, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁IO₁₁.

5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-2-(phenylmethyl)-1,3-benzenediol, CAS: 1610531-11-7, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈O₃.

5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-2-(phenylmethyl)-1,3-benzenediol-d7, CAS: /, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₁D₇O₃.

5-[(1E)-2-[4-(Phenylmethoxy)phenyl]ethenyl]-1,3-benzenediol, CAS: 637776-91-1, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈O₃.

5-[(1E)-2-[4-(Phenylmethoxy)phenyl]ethenyl]-1,3-benzenediol-d7, CAS: /, stock: 8.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₁D₇O₃.

Allyl Bromide (Stabilized with Propylene Oxide), CAS: 106-95-6, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅Br.

Allyl-d5 Bromide, CAS: 102910-37-2, stock: 5.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃D₅Br.

Azo-Resveratrol, CAS: 1393556-48-3, stock: 7.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₃.

cis Resveratrol 3,5-Diacetate, CAS: /, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆O₅.

cis Resveratrol 3-O-β-D-Glucuronide Methyl Ester, CAS: /, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂O₉.

cis Resveratrol 4’-O-β-D-Glucuronide, CAS: 387372-26-1, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀O₉.

cis Resveratrol 4’-O-β-D-Glucuronide Methyl Ester, CAS: /, stock: 1.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂O₉.

cis Resveratrol Penta-O-acetyl-4’-β-D-glucuronide Methyl Ester, CAS: /, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂O₁₄.

cis Resveratrol Triacetate, CAS: /, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈O₆.

cis-3,4’,5-Trimethoxy-3’-aminostilbene, CAS: 586410-12-0, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₃.

cis-3,5-Lupetidine-d4, CAS: /, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁D₄N.

cis-Piceatannol, CAS: 106325-86-4, stock: 4.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₄.

cis-Resveratrol, CAS: 61434-67-1, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₃.

cis-Resveratrol 3-O-β-D-Glucuronide (contains up to 15% trans isomer), CAS: 387372-23-8, stock: 2.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀O₉.

cis-Stilbene, CAS: 645-49-8, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂.

cis-trismethoxy Resveratrol, CAS: 94608-23-8, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈O₃.

Diallyl Tetrasulfide, CAS: 2444-49-7, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀S₄.

Dihydroresveratrol, CAS: 58436-28-5, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄O₃.

Mulberroside A, CAS: 102841-42-9, stock: 3.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂O₁₄.

Oxyresveratrol, CAS: 29700-22-9, stock: 2.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₄.

Polydatin, CAS: 65914-17-2, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃O₉.

Resveratrol, CAS: 501-36-0, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₃.

Resveratrol 3,4’-Diacetate, CAS: 861446-14-2, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆O₅.

Resveratrol 3-Sulfate-4’-glucuronide, CAS: 1028964-64-8, stock: 7.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀O₁₂S.

Resveratrol-13C6, CAS: 1185247-70-4, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₆H₁₂O₃.

Resveratrol-d4, CAS: 1089051-56-8, stock: 2.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈D₄O₃.

Resveratroloside, CAS: 38963-95-0, stock: 4.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₈.

Rhapontigenin, CAS: 500-65-2, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₄.

Tetra-O-(tert-butyldimethyl)silyl cis-Piceatannol, CAS: 106325-84-2, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₈O₄Si₄.

trans Resveratrol 3-O-β-D-glucopyranoside, 98%, CAS: 27208-80-6, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₈.

trans Resveratrol 3-Sulfate Sodium Salt, CAS: 858127-11-4, stock: 6.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NaO₆S.

trans Resveratrol Penta-O-acetyl-3-β-D-glucuronide Methyl Ester, CAS: 490028-22-3, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂O₁₄.

trans Resveratrol Penta-O-acetyl-4’-β-D-glucuronide Methyl Ester, CAS: 490028-19-8, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂O₁₄.

trans Resveratrol-13C6 3-Sulfate Sodium Salt, CAS: 1331643-34-5, stock: 6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₆H₁₁NaO₆S.

trans Resveratrol-3,4’,5-trisulfate Trisodium Salt, CAS: /, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉Na₃O₁₂S₃.

trans Resveratrol-3,5-disulfate, CAS: 858187-21-0, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₉S₂.

O-Pentylresorufin, CAS: 87687-03-4, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₃.

O-Pentylresorufin-d11, CAS: 1329614-81-4, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₆D₁₁NO₃.

trans Resveratrol-4’-sulfate, CAS: 858187-19-6, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₆S.

trans-Piceatannol, CAS: 10083-24-6, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₄.

O-Resorufinyl (Di-lauryl)glyceryl Glutarate, CAS: 110033-82-4, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₆₇NO₈.

Resorufin, CAS: 635-78-9, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇NO₃.

trans-Piceatannol-d3, CAS: /, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉D₃O₄.

trans-Piceatannol-d3 (major), CAS: /, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉D₃O₄.

Resorufin (D6, 98%), CAS: 1196157-65-9, stock: 9.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂HD₆NO₃.

Resorufin Acetate, CAS: 1152-14-3, stock: 6.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉NO₄.

trans-Resveratrol 3-O-β-D-Glucuronide, CAS: 387372-17-0, stock: 1.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀O₉.

trans-Resveratrol 4’-O-β-D-Glucuronide, CAS: 387372-20-5, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀O₉.

Resorufin beta-D-Glucuronide Sodium Salt, CAS: 125440-91-7, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄NNaO₉.

trans-Resveratrol Triacetate, CAS: 42206-94-0, stock: 2.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈O₆.

trans-Resveratrol-13C6 3-O-β-D-Glucuronide, CAS: /, stock: 9.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³C₆H₂₀O₉.

Resorufin β-D-Galactopyranoside, CAS: 95079-19-9, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₈.

trans-Resveratrol-3,4’,5-trisulfate Trisodium Salt, CAS: 1595220-20-4, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉Na₃O₁₂S₃.

trans-Resveratrol-d4  4’-O-β-D-Glucuronide, CAS: /, stock: 8.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆D₄O₉.

Resorufin β-D-Glucopyranoside, CAS: 101490-85-1, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₈.

Resorufin Sodium Salt ~90%, CAS: 34994-50-8, stock: 2.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆NNaO₃.

5’-Iodoresiniferatoxin, CAS: 535974-91-5, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₉IO₉.

6’-Iodoresiniferatoxin, CAS: 335151-55-8, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₉IO₉.

PPAHV, CAS: 175796-50-6, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₄O₁₁.

Resiniferatoxin (80%), CAS: 57444-62-9, stock: 4.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₀O₉.

Resiniferonol 9,13,14-Orthophenylacetate, CAS: 57852-42-3, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂O₆.

2-(Ethoxymethyl)-α,α-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol-d5, CAS: /, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₅N₃O₂.

O-deethylated Resiquimod, CAS: 144875-23-0, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₄O₂.

Resiquimod, CAS: 144875-48-9, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₄O₂.

Resiquimod-d5, CAS: /, stock: 1.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇D₅N₄O₂.

3-Acetyl-4-hydroxy-7,8-dimethyl-2(1H)-quinolinone, CAS: 63768-46-7, stock: 2.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃NO₃.

3-[(2,3-Dimethylphenyl)amino]-3-oxo-proponic Acid Ethyl Ester, CAS: 104330-55-4, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃.

4-Hydroxy-7,8-dimethyl-2(1H)-quinolinone, CAS: 54675-03-5, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₂.

5,6-Dihydro-7,8-dimethyl-4,5-dioxo-4H-pyrano[3,2-c]quinoline-2-carboxylic Acid, CAS: 63768-47-8, stock: 4.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁NO₅.

7,8-Dimethylquinoline-2,4-diyl Diacetate, CAS: /, stock: 1.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₄.

Ethyl 5,6-Dihydro-7,8-dimethyl-4,5-dioxo-4H-pyrano[3,2-c]quinoline-2-carboxylic Acid Ester, CAS: 73080-75-8, stock: 4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅NO₅.

Repirinast (>80%), CAS: 73080-51-0, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₅.

Repirinast-d4, CAS: 1329836-95-4, stock: 6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇D₄NO₅.

(4-Carboxy-3-ethoxy)phenyl Acetic Acid, CAS: 220438-80-2, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₅.

rac-1-[2-(Cyano)phenyl]-3-O-methoxymethyl-3-piperidinol, CAS: 1246818-75-6, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₂.

rac-1-[2-(Cyano)phenyl]-3-piperidinol, CAS: 1246816-21-6, stock: 6.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O.

rac-3-Methyl-1-[2-(1-{3-hydroxy-3-O-methoxymethyl}piperidinyl)phenyl]butylimine, CAS: 1246816-58-9, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O₂.

Repaglinide Acyl-β-D-glucuronide, CAS: 1309112-13-7, stock: 5.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₄N₂O₁₀.

Repaglinide Acyl-β-D-glucuronide Benzyl Ester, CAS: /, stock: 1.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₀N₂O₁₀.

N-(4-Chloro-2-(2-chlorobenzoyl)phenyl)-3,4-dimethoxybenzenesulfonamide, CAS: 140916-61-6, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇Cl₂NO₅S.

N-[4-Chloro-2-(2-chlorobenzoyl)phenyl]-N-[(3,4-dimethoxyphenyl)sulfonyl]glycyl-L-prolinamide, CAS: 271246-51-6, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇Cl₂N₃O₇S.

Relcovaptan, CAS: 150375-75-0, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇Cl₂N₃O₇S.

Relcovaptan-d6, CAS: /, stock: 4.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₁D₆Cl₂N₃O₇S.

(2RS,3RS)-1-Chloroacetylamino-3-(2-ethoxy-d5-phenoxy)-2-hydroxy-3-phenylpropane, CAS: 1184995-73-0, stock: 1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇D₅ClNO₄.

(2RS,3RS)-1-Chloroacetylamino-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropane, CAS: 93852-40-5, stock: 5.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂ClNO₄.

Reboxetine, CAS: 71620-89-8, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃NO₃.

rel-(2R,3R)-6-[α-(2-Ethoxy-d5-phenoxy)benzyl]morpholin-3-one, CAS: 1292840-26-6, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆D₅NO₄.

rel-(2R,3R)-6-[α-(2-Ethoxyphenoxy)benzyl]morpholin-3-one, CAS: 98769-79-0, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₄.

4-Deschloro-2-chlorobenzoyl Rebapimide, CAS: 90098-06-9, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅ClN₂O₄.

Rebamipide, CAS: 90098-04-7, stock: 6.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅ClN₂O₄.

Rebamipide-d4, CAS: 1219409-06-9, stock: 4.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₁D₄ClN₂O₄.

(S)-(-)-1,2-Diaminopropane Dihydrochloride, CAS: 19777-66-3, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₀N₂ • 2(HCl).

Dexrazoxane N-Oxide, CAS: /, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₄O₆.

(-)-N-Trifluoroacetyl-1-aminoindan, CAS: 155666-94-7, stock: 1.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀F₃NO.

(1R)-2,3-Dihydro-N-2-propen-1-yl-1H-inden-1-amine Ethanedioate, CAS: 1166392-43-3, stock: 4.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO₄.

(3R)-2,3-Dihydro-3-(2-propyn-1-ylamino)-1H-inden-1-one, CAS: 1312077-05-6, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO.

(3R)-3-Amino-2,3-dihydro-1H-inden-1-one Hydrochloride, CAS: 876725-64-3, stock: 1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO  • (HCl).

(R)-3-Aminoindan-5-ol, CAS: 169105-01-5, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO.

(R,R)-trans-1-Deshydroxy Rasagiline, CAS: 1276516-73-4, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO.

(S)-1-Aminoindane, CAS: 61341-86-4, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N.

(S)-1-Aminoindane-d3, CAS: 1795787-04-0, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈D₃N.

(S)-Rasagiline Mesylate, CAS: 202464-89-9, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃S.

(S)-Rasagiline-13C3 Mesylate, CAS: 1391068-00-0, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₃H₁₇NO₃S.

(S,S)-trans-1-Deshydroxy Rasagiline, CAS: /, stock: 1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO.

5,6-Dihydro-7H-cyclopenta[b]pyridin-7-one, CAS: 31170-78-2, stock: 7.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO.

cis-N-(3-Chloroallyl)-1-(R)-aminoindan Hydrochloride, CAS: 1175018-80-0, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄ClN  •  HCl.

Lactosyl Rasagline, CAS: /, stock: 8.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃NO₁₀.

Lactosyl Rasagline-13C3, CAS: /, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁¹³C₃H₃₃NO₁₀.

N-2-Propynyl Rasagiline Hydrochloride, CAS: 10409-00-4, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆ClN.

N-Despropargyl N-(1-Chloroprop-1-ene) Rasagiline, CAS: 1175018-74-2, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄ClN.

N-Despropargyl N-(2-Chloroallyl) Rasagiline, CAS: 1175018-73-1, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄ClN.

N-[(1R)-2,3-Dihydro-3-oxo-1H-inden-1-yl]-2,2,2-trifluoroacetamide, CAS: 1266231-96-2, stock: 4.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈F₃NO₂.

rac Rasagiline-13C3 Mesylate, CAS: 1216757-55-9, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₃H₁₇NO₃S.

rac-cis-1-Deshydroxy Rasagiline, CAS: 1429220-15-4, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO.

rac-Rasagiline-13C3 N-Carbamoyl β-D-Glucuronide, CAS: /, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₃H₂₁NO₈.

rac-trans-1-Deshydroxy Rasagiline, CAS: 1429220-16-5, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO.

Rasagiline, CAS: 136236-51-6, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N.

Rasagiline Mesylate, CAS: 161735-79-1, stock: 8.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃S.

Rasagiline N-Carbamoyl β-D-Glucuronide, CAS: /, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₈.

Rasagiline N-β-D-Glucuronide Methyl Ester, CAS: /, stock: 1.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃NO₆.

Rasagiline N-β-D-Glucuronide Sodium Salt, CAS: /, stock: 8.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀NNaO₆.

Rasagiline Tri-O-acetyl-N-β-D-glucuronide Methyl Ester, CAS: /, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉NO₉.

Rasagiline-13C3 Hydrochloride, CAS: /, stock: 4.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³C₃H₁₄ClN.

Rasagiline-13C3 Mesylate, CAS: 1391052-18-8, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₃H₁₇NO₃S.

trans-N-(3-Chloroallyl)-1-(R)-aminoindan Hydrochloride, CAS: 1175018-78-6, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄ClN  •  (HCl).

(19E/Z)-seco Rapamycin Sodium Salt, (>80% HPLC), CAS: 148554-65-8, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₇₈NNaO₁₃.

2,4-Dichloro-5,7-dihydro-7,7-dimethylfuro[3,4-d]pyrimidine, CAS: 1260088-72-9, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈Cl₂N₂O.

28-Epirapamycin, CAS: 253431-35-5, stock: 3.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₇₉NO₁₃.

28-O-Methyl-rapamycin, CAS: 159351-88-9, stock: 1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₈₁NO₁₃.

3-(2-Amino-5-benzoxazolyl)-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, CAS: 1224844-38-5, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N₇O.

33-O-Formyl Rapamycin, CAS: /, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₇₉NO₁₄.

42-O-Formyl Rapamycin, CAS: 1237826-25-3, stock: 5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₇₉NO₁₄.

42-O-[(1,1-Dimethylethyl)dimethylsilyl]rapamycin, CAS: 143030-02-8, stock: 8.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₉₃NO₁₃Si.

42-O-[2-[[Hydroxy(2-bromoethoxy)phosphinyl]oxy]ethyl] Rapamycin, CAS: /, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₅H₈₇BrNO₁₇P.

7-O-Demethyl Rapamycin (~80%), CAS: 151519-50-5, stock: 5.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₇₇NO₁₃.

7-O-Desmethyl Temsirolimus, CAS: 408321-08-4, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₅H₈₅NO₁₆.

7-O-Desmethyl Temsirolimus-d3, CAS: /, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₅H₈₂D₃NO₁₆.

9,14-Deepoxy-15-deoxo-14-deoxy-9,15-epoxy-15-hydroxy-14-oxorapamycin, CAS: 150821-39-9, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₇₉NO₁₃.

9,14-Deepoxy-15-deoxo-14-deoxy-9,15-epoxy-15-hydroxy-42-O-14-oxorapamycin, CAS: /, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₇₉NO₁₃.

(R)-1-(2-((2,6-Dimethylphenyl)amino)-2-oxoethyl)-4-(2-hydroxy-3-(2-methoxy-6-(trifluoromethyl)phenoxy)propyl)piperazin-1-ium, CAS: /, stock: 5.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃F₃N₃O₄⁺.

Autophinib, CAS: 1644443-47-9, stock: 2.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁ClN₆O₃.

AZD8055, CAS: 1009298-09-2, stock: 2.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁N₅O₄.

(R)-2-(4-(2-Hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)-N-(o-tolyl)acetamide, CAS: /, stock: 5.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁N₃O₄.

(R)-2-(4-(3-(2,6-Dimethoxyphenoxy)-2-hydroxypropyl)piperazin-1-yl)-N-(2,6-dimethylphenyl)acetamide, CAS: /, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₅N₃O₅.

Bovine MAPKAP1 (Target of rapamycin complex 2 subunit MAPKAP1) ELISA Kit (96T), CAS: /, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(R)-2-(4-(3-(2-(tert-Butoxy)phenoxy)-2-hydroxypropyl)piperazin-1-yl)-N-(2,6-dimethoxyphenyl)acetamide, CAS: /, stock: 8.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉N₃O₆.

Bovine MLST8 (Target of rapamycin complex subunit LST8) ELISA Kit (96T), CAS: /, stock: 1.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chicken MAPKAP1 (Target of rapamycin complex 2 subunit MAPKAP1) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(R)-2-(4-(3-(2-Chloro-6-methoxyphenoxy)-2-hydroxypropyl)piperazin-1-yl)-N-(2,6-dimethylphenyl)acetamide, CAS: /, stock: 9.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂ClN₃O₄.

(R)-N-(2,6-Dimethoxyphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenethoxy)propyl)piperazin-1-yl)acetamide, CAS: /, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇N₃O₆.

(R)-N-(2,6-Dimethoxyphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide, CAS: /, stock: 4.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃N₃O₆.

(R)-N-(2,6-Dimethylbenzyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide, CAS: /, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₅N₃O₄.

(R)-N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(3-methoxyphenoxy)propyl)piperazin-1-yl)acetamide, CAS: /, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃N₃O₄.

(R)-N-(2,6-Dimethylphenyl)-2-(4-(3-(2-fluoro-6-methoxyphenoxy)-2-hydroxypropyl)piperazin-1-yl)acetamide, CAS: /, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂FN₃O₄.

(S)-N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-((2-methoxyphenyl)amino)propyl)piperazin-1-yl)acetamide, CAS: /, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C427.56₂₄H₃₄N₄O₃.

GSK 2126458, CAS: 1086062-66-9, stock: 3.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₇F₂N₅O₃S.

Human MLST8 (Target of rapamycin complex subunit LST8) ELISA Kit (96T), CAS: /, stock: 3.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

1,2-O-(1-Ranolazineethylidene)-4,5-di-O-acetyl-α-D-galactopyranuronic Acid Methyl Ester, CAS: /, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₉N₃O₁₃.

Ku 0063794, CAS: 938440-64-3, stock: 8.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁N₅O₄.

Mouse Mapkap1 (Target of rapamycin complex 2 subunit MAPKAP1) ELISA Kit (96T), CAS: /, stock: 6.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Mlst8 (Target of rapamycin complex subunit LST8) ELISA Kit (96T), CAS: /, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

NVP-BAG956, CAS: 853910-02-8, stock: 1.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₁N₅.

Desmethyl Ranolazine β-D-Glucuronide (mixture of diastereomers), CAS: 172300-93-5, stock: 3.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₉N₃O₁₀.

Rapamycin, CAS: 53123-88-9, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₇₉NO₁₃.

Rapamycin 31,42-Bis(2,2,5-trimethyl-1,3-dioxane-5-carboxylate), CAS: 1401284-72-7, stock: 2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₇H₁₀₃NO₁₉.

Rapamycin 31,42-Bis(2,2,5-trimethyl-1,3-dioxane-5-carboxylate)-d3, CAS: /, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₇H₁₀₀D₃NO₁₉.

Rapamycin Dialdehyde, CAS: 500733-49-3, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₇₉NO₁₅.

Rapamycin-13C,d3 (contains d0) Technical Grade, CAS: /, stock: 4.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀¹³CH₇₆D₃NO₁₃.

Rapamycin-31,42-Diester Impurity, CAS: /, stock: 3.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₁H₉₅NO₁₉.

Rapamycin-d3 (contains d0) Technical Grade, CAS: 392711-19-2, stock: 9.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₇₆D₃NO₁₃.

Rat Mapkap1 (Target of rapamycin complex 2 subunit MAPKAP1) ELISA Kit (96T), CAS: /, stock: 9.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Mlst8 (Target of rapamycin complex subunit LST8) ELISA Kit (96T), CAS: /, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Ridaforolimus, >80%, CAS: 572924-54-0, stock: 9.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₈₄NO₁₄P.

Secorapamycin B, CAS: 185107-79-3, stock: 9.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₈₁NO₁₄.

N-(2,6-Dimethylphenyl)-2,2-dichloroacetamide, CAS: 39084-88-3, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁Cl₂NO.

SMER3, CAS: 67200-34-4, stock: 5.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₄N₄O₂.

N-(2,6-Dimethylphenyl)-2,2-dichloroacetamide-d9, CAS: /, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂D₉Cl₂NO.

N-(2,6-Dimethylphenyl)-2-(4-(2-(2-hydroxy-3-(2-methoxyphenoxy)propoxy)-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide, CAS: 1983943-76-5, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₅N₃O₇.

Temsirolimus (~90%), CAS: 162635-04-3, stock: 8.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₈₇NO₁₆.

Temsirolimus Acetonide, CAS: 162635-03-2, stock: 5.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₉H₉₁NO₁₆.

Temsirolimus Isomer C, CAS: 1027067-40-8, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₈₇NO₁₆.

Temsirolimus Isomer C-d3, CAS: /, stock: 2.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₈₄D₃NO₁₆.

Temsirolimus-13C3,d7, CAS: /, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃¹³C₃H₈₀D₇NO₁₆.

Temsirolimus-d3, CAS: /, stock: 6.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₈₄D₃NO₁₆.

Ranolazine 1-N-Oxide, CAS: /, stock: 8.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃N₃O₅.

Ranolazine 2,3,4-Tri-O-isobutyryl-β-D-Glucuronide Methyl Ester (mixture of diastereomers), CAS: /, stock: 5.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₆₁N₃O₁₃.

Temsirolimus-d7, CAS: 1132660-51-5, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₈₀D₇NO₁₆.

Ranolazine 4-N-Oxide, CAS: /, stock: 6.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃N₃O₅.

Torin 2, CAS: 1223001-51-1, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₅F₃N₄O.

Umirolimus, CAS: 851536-75-9, stock: 7.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₅H₈₇NO₁₄.

WYE-125132, CAS: 1144068-46-1, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃N₇O₄.

WYE-687, CAS: 1062161-90-3, stock: 5.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂N₈O₃.

Ranolazine β-D-Glucuronide (mixture of diastereomers), CAS: /, stock: 6.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₁N₃O₁₀.

Ranolazine N-3-(2-Methoxyphenoxy)-2-hydroxypropane, CAS: /, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₅N₃O₇.

XL388, CAS: 1251156-08-7, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂FN₃O₄S.

Zotarolimus, >90%, CAS: 221877-54-9, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₇₉N₅O₁₂.

Zotarolimus-d3, >90%, CAS: /, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₇₆D₃N₅O₁₂.

(Z)-3-(5-((Dimethylamino)methyl)furan-2-yl)-N-(2-(((5-((dimethylamino)methyl)furan-2-yl)methyl)thio)ethyl)-N-methyl-2-nitroprop-1-ene-1,1-diamine, CAS: 112233-25-7, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₃N₅O₄S.

1,1’-N-[Methylenebis(sulphanediylethylene)]bis(N’-methyl-2-nitroethene-1,1-diamine, CAS: 1331637-48-9, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₆O₄S₂.

1,1’-N-[Methylenebis(sulphanediylethylene)]bis(N’-methyl-2-nitroethene-1,1-diamine-d6, CAS: 1331643-21-0, stock: 5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆D₆N₆O₄S₂.

Descarbosy Ranelic Acid, CAS: 1219692-43-9, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₂O₆S.

Ranelic Acid, CAS: 135459-90-4, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₈S.

Strontium Ranelate, CAS: 135459-87-9, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆N₂O₈SSr₂.

5,6-Dihydro-3-(methylamino)-2H-1,4-thiazin-2-one O-[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]oxime, CAS: 112233-24-6, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₄O₂S.

5,6-Dihydro-3-(methylamino)-2H-1,4-thiazin-2-one Oxime Hydrochloride, CAS: 112233-23-5, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀ClN₃OS.

5,6-Dihydro-3-(methylamino)-2H-1,4-thiazin-2-one Oxime-d3 Hydrochloride, CAS: 1346606-31-2, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₃ClN₃OS.

5-(Dimethylaminomethyl)-2-furfuryl Alcohol Hydrochloride, CAS: 81074-81-9, stock: 5.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄ClNO₂.

5-[(Dimethyl-d6-amino)methyl]-2-furanmethanol, CAS: 1189683-82-6, stock: 1.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇D₆NO₂.

5-[(Dimethylamino)methyl]-2-furanmethanol, CAS: 15433-79-1, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NO₂.

5-[(Methylamino)methyl]-2-furanmethanol, CAS: 66357-60-6, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₂.

Bis(methylthio)-2-nitroethylene, CAS: 13623-94-4, stock: 5.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₂S₂.

Demethylamino Ranitidine Acetamide Sodium, CAS: 112251-56-6, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₃NaO₄S.

Demethylamino Ranitidine-d6 Acetamide Sodium, CAS: 1346606-56-1, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂D₆N₃NaO₄S.

Desmethyl Ranitidine, CAS: 66357-25-3, stock: 4.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₄O₃S.

Dimethylaminomethylfurylmethylthioethyl Ranitidine, CAS: 72126-78-4, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₅N₅O₄S₂.

N-Methyl-1-(methylthio)-2-nitroethenamine, CAS: 61832-41-5, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O₂S.

N-Methyl-1-(methylthio)-2-nitroethenamine-d3, CAS: 1331637-53-6, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅D₃N₂O₂S.

N-Methylnitroacetamide, CAS: 72078-82-1, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆N₂O₃.

N-Methylnitroacetamide-d3, CAS: 1795020-80-2, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃D₃N₂O₃.

Ranitidine, CAS: 66357-35-5, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂N₄O₃S.

Ranitidine N,S-Dioxide, CAS: 1185237-42-6, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂N₄O₅S.

Ranitidine N-Oxide, CAS: 73857-20-2, stock: 6.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂N₄O₄S.

Ranitidine S-Oxide, CAS: 73851-70-4, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂N₄O₄S.

(2R,3aR,6aR)-Ramipril, CAS: 129939-63-5, stock: 2.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂N₂O₅.

(R,R,R)-2-Azabicyclo[3.3.0]octane-3-carboxylic Acid Benzyl Ester, CAS: 129101-19-5, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₂.

(S,S,S)-2-Azabicyclo[3.3.0]octane-3-carboxylic Acid, Benzyl Ester, Hydrochloride, CAS: 87269-87-2, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀ClNO₂.

1-epi-Ramipril, CAS: 104195-90-6, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂N₂O₅.

1-epi-Ramiprilat-d5, CAS: /, stock: 4.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₅N₂O₅.

2-epi-Ramipril, CAS: 129939-65-7, stock: 1.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂N₂O₅.

Cyclohexyl Ramipril Analogue, CAS: 99742-35-5, stock: 2.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₈N₂O₅.

Cyclohexyl Ramipril Hydrochloride, CAS: 885516-61-0, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₉ClN₂O₅.

Cyclohexyl Ramipril-d3 Analogue, CAS: /, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₅D₃N₂O₅.

ent-Ramipril, CAS: 1246253-05-3, stock: 2.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂N₂O₅.

Ramipril, CAS: 87333-19-5, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂N₂O₅.

Ramipril (1.0 mg/mL in Methanol), CAS: 87333-19-5, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂N₂O₅.

Ramipril Acyl-α-D-glucuronide Allyl Ester, CAS: /, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₄N₂O₁₁.

Ramipril Acyl-β-D-glucuronide, CAS: 1357570-21-8, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₀N₂O₁₁.

Ramipril Benzyl Ester, CAS: 87269-88-3, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₈N₂O₅.

Ramipril Benzyl Ester-d5, CAS: 1356929-60-6, stock: 2.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₃D₅N₂O₅.

Ramipril Isopropyl Ester, CAS: 295328-72-2, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄N₂O₅.

Ramipril Isopropyl-d3 Ester, CAS: /, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁D₃N₂O₅.

Ramipril Methyl Ester, CAS: 108313-11-7, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀N₂O₅.

Ramipril Methyl-d3 Ester, CAS: /, stock: 4.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇D₃N₂O₅.

Ramipril-d3, CAS: /, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉D₃N₂O₅.

Ramipril-d5, CAS: 1132661-86-9, stock: 8.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇D₅N₂O₅.

Ramipril-d5 (Major), CAS: /, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇D₅N₂O₅.

Ramipril-d5 Acyl-β-D-glucuronide, CAS: /, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₅D₅N₂O₁₁.

Ramiprilat(Mixture of Diastereoisomers), CAS: /, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈N₂O₅.

Ramiprilat, CAS: 87269-97-4, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈N₂O₅.

Ramiprilat Acyl-β-D-glucuronide >65%, CAS: 1357570-22-9, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆N₂O₁₁.

Ramiprilat Sorbitol Amide, CAS: /, stock: 5.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₉N₃O₉.

Ramiprilat-d3(Mixture of Diastereomers), CAS: 1356933-70-4, stock: 1.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅D₃N₂O₅.

Ramiprilat-d5(Mixture of Diastereomers), CAS: 1356837-92-7, stock: 7.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₅N₂O₅.

Ramiprilat-d5 Acyl-β-D-glucuronide(Mixture of Diastereomers), CAS: /, stock: 7.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁D₅N₂O₁₁.

Trandolapril Acyl-β-D-glucuronide, 85%, CAS: 1260617-50-2, stock: 6.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₂N₂O₁₁.

Trandolaprilat Acyl-β-D-glucuronide, 65%, CAS: 1260610-97-6, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈N₂O₁₁.

[2R,3aR,6aR]-1-[(2(R)-2-[[(1R)-1-Ethoxycarbonxyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[6]pyrrole-2-carboxylic Acid, Benzyl Ester, CAS: 1356847-95-4, stock: 3.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₈N₂O₅.

[2S,3aR,6aR]-1-[(2(S)-2-[[(1R)-1-Ethoxycarbonxyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[6]pyrrole-2-carboxylic Acid, Benzyl Ester, CAS: 1356352-52-7, stock: 5.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₈N₂O₅.

[2S-​[1(R*)​,​2α,​3aβ,​6aβ]​]​-1-​(2-​Amino-​1-​oxopropyl)​octahydro-​cyclopenta[b]​pyrrole-​2-​carboxylic Acid Phenylmethyl Ester Hydrochloride, CAS: /, stock: 3.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O₃ •  HCl.

Ramosetron, CAS: 132036-88-5, stock: 7.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇N₃O.

(3-Chloro-6-hydroxy-2-(4-methoxyphenyl)benzo[b]thiophen-5-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone, CAS: /, stock: 4.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈ClNO₄S.

(3-Chloro-6-hydroxy-2-(4-methoxyphenyl)benzo[b]thiophen-7-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone, CAS: /, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈ClNO₄S.

(6-Hydroxy-2-(4-methoxyphenyl)benzo[b]thiophen-7-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone, CAS: /, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₉NO₄S.

2-(4-Hydroxyphenyl)benzo[b]thiophen-6-ol, CAS: 63676-22-2, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₂S.

2-Ethylbenzo[b]thiophene, CAS: 1196-81-2, stock: 1.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀S.

3-​Bromo-​6-​methoxy-​2-​(4-​methoxyphenyl)​benzo[b]thiophene, CAS: 176672-06-3, stock: 3.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃BrO₂S.

3-Chloro-6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene, CAS: 103597-06-4, stock: 8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃ClO₂S.

3-Des[4-(2-Piperidinyl)ethoxy]benzoyl-7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene, CAS: 1391054-73-1, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇NO₄S.

4,4’-Dimethoxystilbene, CAS: 4705-34-4, stock: 4.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₂.

4,6-di(tert-Butyldimethylsily) Raloxifene, CAS: 182249-24-7, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₅NO₄SSi₂.

4-Hydroxy Raloxifene, CAS: 185416-01-7, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇NO₄S.

4-Hydroxy Raloxifene-d4, CAS: /, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₃D₄NO₄S.

4-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene, CAS: 90433-54-8, stock: 5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₂S.

4’-Raloxifene-β-D-glucopyranoside, CAS: 334758-19-9, stock: 3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇NO₉S.

4’-Raloxifene-β-D-glucopyranoside-d4, CAS: /, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₃D₄NO₉S.

4’-tert-Butyldimethylsilyl-6-hydroxy Raloxifene, CAS: 174264-46-1, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₁NO₄SSi.

5-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene, CAS: /, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₄N₂O₆S.

6-Hydroxy-4’-tert-butyldimethylsylyl Raloxifene-d4, CAS: 1189422-34-1, stock: 9.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇D₄NO₄SSi.

6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene, CAS: 63675-74-1, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₂S.

6-Raloxifene-β-D-glucopyranoside, CAS: 334758-18-8, stock: 9.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇NO₉S.

6-Raloxifene-β-D-glucopyranoside-d4, CAS: /, stock: 6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₃D₄NO₉S.

6-tert-Butyldimethylsilyl-4’-hydroxy Raloxifene, CAS: 174264-47-2, stock: 5.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₁NO₄SSi.

6-tert-Butyldimethylsilyl-4’-hydroxy Raloxifene-d4, CAS: 1329611-25-7, stock: 1.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇D₄NO₄SSi.

7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene (Raloxifene Impurity), CAS: 1159977-58-8, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₄N₂O₆S.

Benzo[b]thiophene, CAS: 95-15-8, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆S.

Benzo[b]thiophene-D6, CAS: 1444206-31-8, stock: 2.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈D₆S.

Cabozantinib N-oxide, CAS: 1621681-63-7, stock: 4.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄FN₃O₆.

Cabozantinib-d6, CAS: /, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₈D₆FN₃O₅.

Methyl 1-(4’-tert-Butyldimethylsylyl-6-hydroxyraloxifene-d4)-2,3,4-tri-O-acetyl-β-D-glycopyranuronate, CAS: /, stock: 1.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₃D₄NO₁₃SSi.

Methyl Raloxifene 4’-(2,3,4-Tri-O-acetyl-β-D-glycopyranuronate), CAS: 174264-51-8, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₃NO₁₃S.

Methyl Raloxifene 6-(2,3,4-Tri-O-acetyl-β-D-glycopyranuronate), CAS: /, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₃NO₁₃S.

Methyl Raloxifene-d4 4’-(2,3,4-Tri-O-acetyl-β-D-glycopyranuronate), CAS: /, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₉D₄NO₁₃S.

Methyl Raloxifene-d4 6-(2,3,4-Tri-O-acetyl-β-D-glycopyranuronate), CAS: /, stock: 6.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₉D₄NO₁₃S.

Methyl-1-(4’-tert-butyldimethylsylyl-6-hydroxyraloxifene)-2,3,4-tri-O-acetyl-β-D-glycopyranuronate, CAS: 174264-49-4, stock: 7.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₇NO₁₃SSi.

Methyl-1-(6-tert-butyldimethylsylyl-4’-hydroxyraloxifene)-2,3,4-tri-O-acetyl-β-D-glycopyranuronate, CAS: 174264-48-3, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₇NO₁₃SSi.

Methyl-1-(6-tert-butyldimethylsylyl-4’-hydroxyraloxifene-d4)-2,3,4-tri-O-acetyl-β-D-glycopyranuronate, CAS: /, stock: 4.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₃D₄NO₁₃SSi.

Raloxifene, CAS: 84449-90-1, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇NO₄S.

Raloxifene 4’-Glucuronide, CAS: 182507-22-8, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₅NO₁₀S.

Raloxifene 4’-β-D-Glucuronide Lithium Salt, CAS: /, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₄LiNO₁₀S.

Raloxifene 6,4’-Bis(2,3,4,6-tetra-O-acetyl-β-D-glucuronide Methyl Ester), CAS: /, stock: 9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₅₉NO₂₂S.

Raloxifene 6,4’-Bis-β-D-glucuronide, CAS: 182507-20-6, stock: 9.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₃NO₁₆S.

Raloxifene 6-Glucuronide, CAS: 174264-50-7, stock: 1.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₅NO₁₀S.

Raloxifene 6-β-D-Glucuronide Lithium Salt, CAS: /, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₄LiNO₁₀S.

Raloxifene Dimer, CAS: 618902-12-8, stock: 7.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₅₂N₂O₈S₂.

Raloxifene Dimer-d8, CAS: /, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₄₄D₈N₂O₈S₂.

Raloxifene Dimesylate Hydrochloride, CAS: 84449-85-4, stock: 2.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁NO₈S₃•HCl.

Raloxifene Dimesylate Hydrochloride-d4, CAS: /, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₇D₄NO₈S₃ •HCl.

Raloxifene Hydrochloride, CAS: 82640-04-8, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈ClNO₄S.

Raloxifene N-Oxide, CAS: 195454-31-0, stock: 6.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇NO₅S.

Raloxifene-d10 Hydrochloride, CAS: /, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₈D₁₀ClNO₄S.

Raloxifene-d4, CAS: 1185076-44-1, stock: 2.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₃D₄NO₄S.

Raloxifene-d4 4’-Glucuronide, CAS: /, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₁D₄NO₁₀S.

Raloxifene-d4 4’-β-D-Glucuronide Lithium Salt, CAS: /, stock: 1.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₁D₄LiNO₁₀S.

Raloxifene-d4 6,4’-Bis(2,3,4,6-tetra-O-acetyl-β-D-glucuronide Methyl Ester), CAS: /, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₅₅D₄NO₂₂S.

(11-cis,13-cis)-4-Oxoretinoic Acid, CAS: 112924-95-5, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₃.

Raloxifene-d4 6,4’-Bis-β-D-glucuronide, CAS: /, stock: 5.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₉D₄NO₁₆S.

Raloxifene-d4 6-Glucuronide, CAS: /, stock: 7.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₁D₄NO₁₀S.

(1S,2S)-N-[4-[2-(Dimethylamino)-1-(1H-imidazol-1-yl)]propylphenyl]-2-benzothiazolamine, CAS: 355860-40-1, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₅S.

Raloxifene-d4 6-β-D-Glucuronide Lithium Salt, CAS: /, stock: 1.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₁D₄LiNO₁₀S.

(2E,4E,6E)-3,7-Dimethyl-8-oxo-2,4,6-octatrienoic Acid, CAS: 74479-68-8, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₃.

(2E,​4Z,​6E,​8E)​-​3,​7-​Dimethyl-​9-​(2,​6,​6-​trimethyl-​1,​3-​cyclohexadien-​1-​yl)​-​2,​4,​6,​8-​nonatetraenenitrile, CAS: 1041190-31-1, stock: 2.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N.

Raloxifene-d4 Hydrochloride, CAS: 1188263-47-9, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄D₄ClNO₄S.

XL184, CAS: 849217-68-1, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄FN₃O₅.

(4E)-5-(4-Methoxy-2,3,6-trimethylphenyl)-3-methyl-2,4-pentadienal(cis/trans Mixture), CAS: 419534-29-5, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀O₂.

(4E)-5-(4-Methoxy-d3-2,3,6-trimethylphenyl)-3-methyl-2,4-pentadienal, CAS: 1185247-91-9, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇D₃O₂.

1,3-Oxazinan-2-one, CAS: 5259-97-2, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₂.

(9-cis,13-cis)-12-Carboxy Retinoic Acid, CAS: 99394-38-4, stock: 1.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₄.

2-Des(5-methyl-1,3,4-oxadiazole-2-carboxamide) (E)-2-(N,N-Dimethylformimidamide) Raltegravir, CAS: 1193687-85-2, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄FN₅O₃.

2-Des(5-methyl-1,3,4-oxadiazole-2-carboxamide) 2-(2-(2-Acetylhydrazinyl)-2-oxoacetamide) Raltegravir, CAS: 1391918-17-4, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃FN₆O₆.

(9-cis,13-cis)-Retinoic Acid Ethyl Ester, CAS: 86708-68-1, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂O₂.

(9-cis,13-cis)-Retinoic Acid Methyl Ester, CAS: 68070-33-7, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₂.

2-Des(5-methyl-1,3,4-oxadiazole-2-carboxamide) 2-(2-Amino-2-oxoacetic Acid) Raltegravir, CAS: 1064706-98-4, stock: 3.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉FN₄O₆.

4-Defluoro Raltegravir, CAS: 1193687-87-4, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₆O₅.

(E,E)-6-α-Ionylidene-4-methylpyran-2-one, CAS: 87424-83-7, stock: 1.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₂.

(E,E)-6-α-Ionylidene-4-methylpyran-2-one-d5, CAS: 1331668-72-4, stock: 6.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₅O₂.

4-Defluoro Raltegravir-d7, CAS: /, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅D₇N₆O₅.

5-Hydroxy-2-[1-methyl-1-[[benzylcarbamoyl]amino]ethyl]-6-methoxypyrimidine-4-carboxylic Acid Methyl Ester, CAS: 1159977-42-0, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁N₃O₆.

(Z)-3-Methyl-4-phosphono-crotonic Acid Triethyl Ester, CAS: 3917-43-9, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁O₅P.

1,3,3-Trimethyl-2-[(1,3-hexadien-5-ynyl)-trimethylsilyl]-cyclohexane, CAS: /, stock: 3.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈Si.

5-Hydroxy-2-[1-methyl-1-[[benzylcarbamoyl]amino]ethyl]-6-methoxypyrimidine-4-carboxylic Acid Methyl Ester-d3, CAS: 1185032-53-4, stock: 8.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈D₃N₃O₆.

5-Methyl-1H-1,2,4-triazole-3-carboxylic Acid, CAS: 7169-98-4, stock: 7.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃O₂.

1,3,3-Trimethyl-2-[(1E,3E)-3-methyl-1,3-hexadien-5-ynyl]-cyclohexane, CAS: 25576-25-4, stock: 8.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂.

Ethyl 2-[[1-[4-[[[(4-fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]amino]-2-oxoacetate, CAS: 1193687-88-5, stock: 4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃FN₄O₆.

Methyl [[1-[4-[[(4-Fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]amino](oxo)acetate, CAS: 518048-04-9, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁FN₄O₆.

1,3,3-Trimethyl-2-[(1E,3E)-3-methyl-6-(trimethylsilyl)-1,3-hexadien-5-yn-1-yl]-cyclohexene, CAS: 228120-22-7, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₀Si.

MK-2048, CAS: 869901-69-9, stock: 3.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁ClFN₅O₄.

N-((5-Hydroxy-6-oxo-4-((2,4,6-trifluorobenzyl)carbamoyl)-1,6-dihydropyrimidin-2-yl)methyl)-1,3,4-oxadiazole-2-carboxamide, CAS: /, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁F₃N₆O₅.

1-(2-tert-Butyl-4-bromophenyl)pyrrolidin-2-one, CAS: 895543-25-6, stock: 6.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈BrNO.

N1,N2-bis[1-[4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]ethanediamide, CAS: 1391918-18-5, stock: 1.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₆F₂N₈O₈.

N1-[1-[4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]ethanediamide, CAS: 1193687-86-3, stock: 9.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀FN₅O₅.

11,12-Dihydro-11-hydroxyretinoic Acid δ-Lactone, CAS: /, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₅O₂.

Raltegravir, CAS: 518048-05-0, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁FN₆O₅.

(1,2,6,7,-Tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)acetonitrile, CAS: 221530-44-5, stock: 7.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO.

11-cis-Retinoic Acid Methyl Ester, CAS: 25428-67-5, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₂.

Raltegravir 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 4.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₇FN₆O₁₄.

Raltegravir 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester-d3, CAS: /, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄D₃FN₆O₁₄.

(2E)-2-(2,3-Dihydro-6-methoxy-1H-inden-1-ylidene)acetonitrile, CAS: 187871-98-3, stock: 3.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO.

(2E)-2-(2,3-Dihydro-6-methoxy-1H-inden-1-ylidene)ethanamine, CAS: 178676-73-8, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO.

11-cis-Retinoic Acid-d5, CAS: 78996-15-3, stock: 7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₅O₂.

13-cis Retinoic Acid Methyl Ester, CAS: 16760-45-5, stock: 1.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₂.

Raltegravir β-D-Glucuronide, CAS: 952654-62-5, stock: 9.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₉FN₆O₁₁.

Raltegravir β-D-Glucuronide Methyl Ester, CAS: /, stock: 1.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁FN₆O₁₁.

(2Z)-2-(2,3-Dihydro-6-methoxy-1H-inden-1-ylidene)acetonitrile, CAS: 468104-14-5, stock: 9.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO.

(E)-2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-ylidene)ethylamine, CAS: 196597-61-2, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO.

13-cis Retinoic Acid-d5 Methyl Ester, CAS: 1331666-29-5, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅D₅O₂.

Raltegravir β-D-Glucuronide Methyl Ester-d3, CAS: /, stock: 4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈D₃FN₆O₁₁.

Raltegravir Potassium Salt, CAS: 871038-72-1, stock: 7.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀FKN₆O₅.

(E)-N-[2-(2,3-Dihydro-6-methoxy-1H-inden-1-ylidene)ethyl]propanamide, CAS: 196597-82-7, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₂.

13-cis-Retinoic Acid Ethyl Ester, CAS: 59699-82-0, stock: 4.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂O₂.

Raltegravir-13C,d3, CAS: /, stock: 8.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉¹³CH₁₈D₃FN₆O₅.

(R)-Ramelteon Metabolite M-II, CAS: /, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₃.

(S)-N-[2-(2,3-Dihydro-6-methoxy-1H-inden-1-yl)ethyl]propanamide, CAS: 178678-16-5, stock: 6.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₂.

Raltegravir-13C6 Potassium Salt, CAS: 1391053-33-0, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³C₆H₂₀FKN₆O₅.

Raltegravir-d3 β-D-Glucuronide, CAS: /, stock: 4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆D₃FN₆O₁₁.

(S)-N-[2-(5-Bromo-2,3-dihydro-6-hydroxy-1H-inden-1-yl)ethyl]propanamide, CAS: 196597-84-9, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈BrNO₂.

(S)-N-[2-(5-Bromo-2,3-dihydro-6-methoxy-1H-inden-1-yl)ethyl]propanamide, CAS: 196597-83-8, stock: 7.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀BrNO₂.

13-cis-Retinoic Acid-d5 Ethyl Ester, CAS: 78995-96-7, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇D₅O₂.

Raltegravir-d3 Potassium Salt, CAS: 1246816-98-7, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇D₃FKN₆O₅.

(S)-N-[2-[2,3-Dihydro-6-hydroxy-7-(2-hydroxyethyl)-1H-inden-1-yl]ethyl]propanamide, CAS: 196597-88-3, stock: 9.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₃.

(S)-N-[2-[6-Allyloxy-5-bromo-2,3-dihydro-1H-inden-1-yl]ethyl]propanamide, CAS: 1246820-28-9, stock: 4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀BrNO₂.

14-Hydroxy-retro Retinyl Acetate, CAS: /, stock: 6.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂O₃.

(S)-N-[2-[7-Allyl-5-bromo-2,3-dihydro-6-hydroxy-1H-inden-1-yl]ethyl]propanamide, CAS: 196597-86-1, stock: 6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂BrNO₂.

(S)-N-[2-[7-Allyl-5-bromo-6-benzyloxy-2,3-dihydro-1H-inden-1-yl]ethyl]propanamide, CAS: 1246820-29-0, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈BrNO₂.

(S)-N-[6-Benzyloxy-5-bromo-7-(2-hydroxyethyl)-2,3-dihydro-1H-inden-1-ylidene)ethyl]propanamide, CAS: 1246820-32-5, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈BrNO₃.

(S)-Ramelteon Metabolite M-II, CAS: /, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₃.

(E/Z)-4-(4’-Hydroxyphenyl)-2-butanone-d5 Oxime, CAS: 1185238-88-3, stock: 8.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₅NO₂.

4-Acetyl Ramelteon, CAS: 1346598-94-4, stock: 7.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NO₃.

4-Hydroxy Ramelteon, CAS: 1204581-50-9, stock: 3.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₃.

2-((2-Hydroxy-2-(4-hydroxyphenyl)ethyl)(4-(4-hydroxyphenyl)butan-2-yl)amino)-1-(4-hydroxyphenyl)ethanone, CAS: /, stock: 9.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₉NO₅.

4-Hydroxy Ramelteon β-D-Glucuronide, CAS: /, stock: 3.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉NO₉.

3-Deazaneplanocin, HCl Salt, CAS: /, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₄O₃•HCl.

2-(4-(4-Nitrophenyl)butan-2-ylamino)-1-(4-methoxyphenyl)ethanal Hydrochloride, CAS: 1346603-04-0, stock: 5.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O₄.

2-(4-(4-Nitrophenyl)butan-2-ylamino)-1-(4-methoxyphenyl)ethanol Hydrochloride, CAS: 1346600-92-7, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅ClN₂O₄.

Despropionyl Ramelteon Hydrochloride, CAS: 196597-80-5, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈ClNO.

3-Hydroxy-2,6,6-trimethyl-1-cyclohexene-1-carbonitrile, CAS: 145106-79-2, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO.

N-[2-[(1S)-5-bromo-2,3-dihydro-6-(2-propen-1-yloxy)-1H-inden-1-yl]ethyl]propanamide, CAS: 196597-85-0, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂BrNO₂.

3-[[(tert-Butyl)dimethylsilyl]oxy]retinoic Acid Ethyl Ester, CAS: /, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O₃Si.

4,4-Dimethyl Retinoic Acid, CAS: 104182-09-4, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂O₂.

rac-2,3-Dihydro-6-methoxy-1H-indene-1-ethanamine, CAS: 108048-37-9, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO.

rac-N-[2-(2,3-Dihydro-6-methoxy-1H-inden-1-yl)ethyl]propanamide, CAS: 178677-89-9, stock: 4.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₂.

4,4-Dimethyl Retinoic Acid-d3, CAS: 1346606-19-6, stock: 8.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉D₃O₂.

4,4-Dimethyl-1-tetralone, CAS: 2979-69-3, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O.

4,4-Dimethyl-7-ethynyl-1-tetralone, CAS: 166978-48-9, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄O.

4-​oxo-9-cis-Retinoic Acid β-​D-​Glucopyranuronosyl Ester, CAS: 159992-06-0, stock: 1.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄O₉.

Butopamine Hydrochloride, CAS: 74432-68-1, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄ClNO₃.

Butopamine-d4 Hydrochloride, CAS: 1346600-56-3, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀D₄ClNO₃.

4-Keto 13-cis-Retinoic Acid Methyl Ester, CAS: 71748-57-7, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₃.

4-Keto 13-cis-Retinoic-d3 Acid Methyl Ester, CAS: /, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅D₃O₃.

4-Keto 9-cis Retinoic Acid, CAS: 150737-18-1, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₃.

4-Keto 9-cis Retinoic Acid Methyl Ester, CAS: 163955-59-7, stock: 5.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₃.

4-Keto 9-cis Retinoic Acid-d3, CAS: 1185241-31-9, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₃O₃.

N-(4-Hydroxy)benzyl Ractopamine, CAS: 1330264-65-7, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉NO₄.

N-[β-Hydroxy-β-(4-hydroxyphenyl)ethyl] Ractopamine(Mixture of Diastereomers), CAS: 1797121-82-4, stock: 7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₁NO₅.

4-Keto all-trans-Retinoic Acid Methyl Ester, CAS: 38030-58-9, stock: 7.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₃.

4-Keto Retinal, CAS: 33532-44-4, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₂.

4-Methoxy Retinoic Acid, CAS: 81121-20-2, stock: 9.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₃.

4-Methoxy Retinoic Acid Methyl Ester, CAS: 163808-81-9, stock: 9.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂O₃.

rac Ractopamine Hydrochloride (Mixture of Diastereomers), CAS: 90274-24-1, stock: 8.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄ClNO₃.

4-Oxo-(9-cis,13-cis)-Retinoic Acid, CAS: 1391062-39-7, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₃.

4-Oxo-(9-cis,13-cis)-Retinoic-d7 Acid, CAS: /, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉D₇O₃.

Ractopamine-10-O-β-glucuronide (Mixture of Diastereomers), CAS: 166022-10-2, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁NO₉.

Ractopamine-10-O-β-glucuronide-d6 (Mixture of Diastereomers), CAS: /, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅D₆NO₉.

Ractopamine-10-sulfate, CAS: /, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NO₆S.

Ractopamine-10-sulfate-d6, CAS: /, stock: 1.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₆NO₆S.

4Z-Retinol, CAS: /, stock: 8.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O.

Ractopamine-10’-O-β-glucuronide (Mixture of Diastereomers), CAS: 166022-11-3, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁NO₉.

Ractopamine-10’-O-β-glucuronide-d6 (Mixture of Diastereomers), CAS: /, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅D₆NO₉.

5,6-Dihydro-4-methyl-6-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2H-pyran-2-ol, CAS: 161676-56-8, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O₂.

Ractopamine-10’-sulfate (Mixture of Diastereomers), CAS: 165897-63-2, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NO₆S.

Ractopamine-10’-sulfate-d6 (Mixture of Diastereomers), CAS: /, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₆NO₆S.

5,6-Dihydro-5,6-dihydroxyretinoic Acid Methyl Ester, CAS: 75664-64-1, stock: 3.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂O₄.

Ractopamine-d5 Hydrochloride, CAS: /, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉D₅ClNO₃.

Ractopamine-d6 Hydrochloride, CAS: 1276197-17-1, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈D₆ClNO₃.

5,8-cis-5,8-Epoxy-13-cis Retinoic Acid, CAS: /, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

Ractopamine-d6 Ketone Hydrochloride, CAS: 1185012-24-1, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₆ClNO₃.

Tri-N,O,O-(4-benzyloxy)benzyl Ractopamine, CAS: 1797884-42-4, stock: 9.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₀H₅₉NO₆.

5,8-Epoxy-9-cis Retinoic Acid, CAS: 1331640-07-3, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

5,​6-​Dihydro-​4-​methyl-​6-​(2,​6,​6-​trimethyl-​1-​cyclohexen-​1-​yl)​-2H-​pyran-​2-​one, CAS: 14393-37-4, stock: 1.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₂.

7-Demethyl-11,12-didehydro-3-methyl Retinol, CAS: /, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆O.

9-cis,13-cis-Retinoic Acid-d5, CAS: 78996-15-3, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₅O₂.

9-cis-13,14-Dihydro 13-Methylretinoic Acid (>80%), CAS: 176019-01-5, stock: 7.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₂.

9-cis-13,14-Dihydro 13-Methylretinoic-d5 Acid (>90%), CAS: /, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₅O₂.

9-cis-5,6-Epoxy-5,6-dihydro-retinoic Acid, CAS: 1431303-55-7, stock: 3.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

9-cis-Retinoic Acid Methyl Ester, CAS: 58526-50-4, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₂.

9-cis-Retinoic Acid-d5, CAS: 78996-15-3, stock: 8.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₅O₂.

AC 41848, CAS: 400856-69-1, stock: 3.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁BrCl₂N₂.

all-trans 4-Keto Retinoic Acid, CAS: 38030-57-8, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₃.

all-trans 4-Keto Retinoic Acid-(9-methyl)-d3, CAS: 1346606-26-5, stock: 9.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₃O₃.

all-trans 5,6-Epoxy Retinoic Acid, CAS: 13100-69-1, stock: 2.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

all-trans 5,6-Epoxy Retinoic Acid-d5, CAS: /, stock: 3.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₅O₃.

all-trans Retinoyl β-D-Glucuronide, >85% By HPLC, CAS: 401-10-5, stock: 1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆O₈.

all-trans-18-Hydroxy Retinoic Acid, CAS: 63531-93-1, stock: 5.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

all-trans-3,4-Didehydro Retinoic Acid, CAS: 4159-20-0, stock: 2.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₂.

all-trans-Retinal, CAS: 116-31-4, stock: 7.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O.

all-trans-Retinoic Acid Methyl Ester, CAS: 339-16-2, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₂.

all-trans-Retinoic Acid-d5 (major), CAS: 78996-15-3, stock: 8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₅O₂.

all-trans-Retinoic Acid-d5 Ethyl Ester, CAS: 78995-96-7, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇D₅O₂.

AR 7, CAS: 80306-38-3, stock: 6.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂ClNO.

Caged Retinoic Acid, CAS: 1040124-47-7, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₇NO₆.

Chicken RARB (Retinoic acid receptor beta) ELISA Kit (96T), CAS: /, stock: 2.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

d-α-Tocopheryl Retinoate, CAS: 40516-49-2, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₇₆O₃.

dl-α-Tocopheryl Retinoate, CAS: 40516-48-1, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₇₆O₃.

Etretinate-d3, CAS: 1185237-13-1, stock: 2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇D₃O₃.

Human CRABP2(Cellular retinoic acid-binding protein 2) ELISA Kit (96T), CAS: /, stock: 8.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human RARB (Retinoic acid receptor beta) ELISA Kit (96T), CAS: /, stock: 3.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human RARB(Retinoic acid receptor beta) ELISA Kit (96T), CAS: /, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human RARα(Retinoic Acid Receptor Alpha) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human RXRB(Retinoic acid receptor RXR-beta) ELISA Kit (96T), CAS: /, stock: 5.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

α-Cyclogeranonitrile, CAS: 57524-13-7, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N.

β-Cyclogeranyltriphenylphosphonium Bromide, CAS: 56013-01-5, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂BrP.

β-Cyclogeranyltriphenylphosphonium Bromide-d5, CAS: 78995-97-8, stock: 1.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇D₅BrP.

1-(1H-Benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid (>75%), CAS: 1163685-30-0, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁N₃O₃.

1-(1H-Benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid Sodium Salt, CAS: /, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₃NaO₃.

2-(Chloromethyl)-4-(3-chloropropoxy)-3-methylpyridine Hydrochloride, CAS: /, stock: 4.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄Cl₃NO.

Methyl 2-(3-Mercaptophenyl)acetate, CAS: 133806-71-0, stock: 9.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₂S.

2-Acetoxymethyl-4-chloro-3-methylpyridine, CAS: 59886-84-9, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀ClNO₂.

2-Acetyloxymethyl-3-methyl-4-(methoxypropoxy)pyridine, CAS: 117977-19-2, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₄.

Methyl 5,6-Monoepoxyretinoate, CAS: 7432-30-6, stock: 3.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₃.

2-Chloromethyl-4-(3-methoxypropoxy)-3-methylpyridine Hydrochloride, CAS: 153259-31-5, stock: 3.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇Cl₂NO₂.

Mouse Crabp2(Cellular retinoic acid-binding protein 2) ELISA Kit (96T), CAS: /, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Rarb (Retinoic acid receptor beta) ELISA Kit (96T), CAS: /, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

3-Methyl-4-oxo-1-(1-(2,2,2-trifluoroethyl)-1H-benzo[d]imidazol-2-yl)-1,4-dihydropyridine-2-carboxylic Acid, CAS: /, stock: 3.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂F₃N₃O₃.

Mouse Rarg (Retinoic acid receptor gamma) ELISA Kit (96T), CAS: /, stock: 5.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Rarβ(Retinoic acid receptor beta) ELISA Kit (96T), CAS: /, stock: 2.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

4-(3-Methoxypropoxy)-3-methylpicolinic Acid, CAS: 1163685-31-1, stock: 7.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₄.

4-Chloro-2,3-dimethylpyridine N-Oxide, CAS: 59886-90-7, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈ClNO.

Mouse Rarγ(Retinoic acid receptor gamma) ELISA Kit (96T), CAS: /, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Rxra( Retinoic acid receptor RXR-alpha) ELISA Kit (96T), CAS: /, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

4-Chloro-2-(chloromethyl)-3-methylpyridine, CAS: 168167-48-4, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇Cl₂N.

Mouse Rxrb( Retinoic acid receptor RXR-beta) ELISA Kit (96T), CAS: /, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Rxrg( Retinoic acid receptor RXR-gamma) ELISA Kit (96T), CAS: /, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Octadecylamine, CAS: 124-30-1, stock: 5.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₉N.

Octadecylamine-d37, CAS: /, stock: 7.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂D₃₇N.

rac 4-Hydroxy-9-cis-retinoic Acid, CAS: 150737-17-0, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

rac 4-Hydroxy-9-cis-retinoic Acid Methyl Ester, CAS: /, stock: 7.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₃.

4-Methylbenzo[4,5]imidazo[1,2-b]pyrido[1,2-d][1,2,4]thiadiazin-3-ol, CAS: /, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁N₃OS.

rac 4-Hydroxy-9-cis-retinoic Acid-d3, CAS: 1346606-78-7, stock: 2.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₃O₃.

rac all-trans  3-(Acetyloxy) Retinol Acetate 90%, CAS: 76686-33-4, stock: 1.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄O₄.

rac all-trans 3-Hydroxy Retinoic Acid Ethyl Ester, CAS: 120674-74-0, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂O₃.

rac all-trans 4-Hydroxy Retinoic Acid, CAS: 66592-72-1, stock: 9.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

rac all-trans 4-Hydroxy Retinoic Acid-d3, CAS: 1346606-21-0, stock: 7.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₃O₃.

rac all-trans-13,14-Dihydro Retinoic Acid Ethyl Ester, CAS: /, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄O₂.

Rac-5,8-trans-5,8-Epoxy-13-cis Retinoic Acid, CAS: /, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

Retinoic Acid 3,3-Dimethyl-2-oxobutyl Ester, CAS: 893412-73-2, stock: 6.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₈O₃.

Retinoic Acid 3,3-Dimethyl-2-oxobutyl Ester-d5, CAS: /, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₃D₅O₃.

Retinoyl Chloride, CAS: 53839-60-4, stock: 8.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇ClO.

Retinyl Retinoate, CAS: 15498-86-9, stock: 6.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₆O₂.

Ro 22-5112, CAS: 73341-58-9, stock: 2.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₄.

Ro 22-5112-d5, CAS: /, stock: 2.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₅O₄.

Talarozole, CAS: 201410-53-9, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₅S.

Triethyl 3-Methyl-4-phosphono-2-butenoate (~90%), CAS: 41891-54-7, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁O₅P.

Trifarotene, CAS: 895542-09-3, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₃NO₄.

Vitamin A2 Nitrile, CAS: 6248-59-5, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N.

Win 18446, CAS: 1477-57-2, stock: 4.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀Cl₄N₂O₂.

[(2E,4E)-3-Methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-pentadien-1-yl]triphenyl-phosphonium Bromide, CAS: 62285-98-7, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₈BrP.

(R)-Quizalofop Ethyl, CAS: 100646-51-3, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇ClN₂O₄.

(R)-Quizalofop Methyl, CAS: 76578-71-7, stock: 6.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅ClN₂O₄.

(R)-Quizalofop-tefuryl, CAS: 200509-41-7, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁ClN₂O₅.

Quizalofop, CAS: 76578-12-6, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃ClN₂O₄.

Quizalofop-ethyl, CAS: 76578-14-8, stock: 9.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇ClN₂O₄.

Quizalofop-P, CAS: 94051-08-8, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃ClN₂O₄.

Quizalofop-p-tefuryl, CAS: 119738-06-6, stock: 1.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁ClN₂O₅.

3-(Acetylthio)-2-benzylpropionic Acid, CAS: 91702-98-6, stock: 1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₃S.

4,5,7-Trichloroquinoline, CAS: 23834-01-7, stock: 3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄Cl₃N.

5,7-Dichloro-4-hydroxyquinoline, CAS: 171850-29-6, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅Cl₂NO.

Quinoxyfen, CAS: 124495-18-7, stock: 4.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈Cl₂FNO.

Quinoxyfen-d4, CAS: /, stock: 3.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₄D₄Cl₂FNO.

(-)-(3S)-3-Hydroxy Quinine, CAS: 78549-61-8, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₃.

(-)-(3S)-3-Hydroxy Quinine-vinyl-d3, CAS: 78549-61-8, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃N₂O₃.

(-)-Dihydroquinine, CAS: 522-66-7, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₂O₂.

(3R)-3-Hydroxy Quinine, CAS: 128241-59-8, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₃.

(3R)-3-Hydroxy Quinine-vinyl-d3, CAS: /, stock: 3.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃N₂O₃.

3-Oxo-3-desvinylquinine 9-Acetate, CAS: 1217524-13-4, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₄.

9-Acetyl-3,10-dihydroxy Hydroquinine, CAS: /, stock: 1.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₂O₅.

9-epi Quinine, CAS: 572-60-1, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₂.

Cinchamidine, CAS: 485-64-3, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₂O.

Ethylhydrocupreine Hydrochloride, CAS: 3413-58-9, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈N₂O₂ •HCl.

Isoquinine, CAS: 697260-51-8, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₂.

α-​[[2-​(1-​Azabicyclo[2.2.2]​oct-​3-​yloxy)​-​1-​cyclopentyl-​1-​phenylethoxy]​methyl]​-​α-​cyclopentyl-benzenemethanol hydrochloride, CAS: 2091937-85-6, stock: 9.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₅NO₃ • (HCl).

Nampt-IN-1, CAS: 1698878-14-6, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N₃O₅S.

Quinine 1’-Oxide, CAS: 54821-44-2, stock: 7.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₃.

Quinine Bisulfate, CAS: 549-56-4, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₂₀H₂₄N₂O₂)₂ •  H₂O₄S.

Quinine Di-N-oxide, CAS: 101655-92-9, stock: 1.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₄.

Quinine Hydrochloride, CAS: 130-89-2, stock: 6.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₂ • HCl.

Quinine N-Oxide, CAS: 109906-48-1, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₃.

Quinine-d3 1’-Oxide, CAS: /, stock: 5.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃N₂O₃.

Quinine-d3 N-Oxide, CAS: /, stock: 3.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃N₂O₃.

Quinotoxine Hydrochloride, CAS: 52211-63-9, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅ClN₂O₂.

Vacquinol-1, CAS: 5428-80-8, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁ClN₂O.

Quinapril-d5 Hydrochloride (Major), CAS: 1356020-03-5, stock: 3.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆D₅ClN₂O₅.

(4R)-6-Chloro-3,4-dihydro-4-hydroxy-3-[(1R)-1-phenylethyl]-4-(trifluoromethyl)-2(1H)quinazolinone, CAS: 497235-42-4, stock: 2.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄ClF₃N₂O₂.

(4S)-6-Chloro-3,4-dihydro-4-hydroxy-3-[(1R)-1-phenylethyl]-4-(trifluoromethyl)-2(1H)quinazolinone, CAS: 247565-03-3, stock: 5.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄ClF₃N₂O₂.

(4S)-6-Chloro-4-(2-cyclopropylethynyl)-3,4-dihydro-3-[(1R)-1-phenylethyl]-4-(trifluoromethyl)-2(1H)-quinazolinone, CAS: /, stock: 1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈ClF₃N₂O.

(5-Amino-6-(methoxy-d3)pyrazin-2-yl)boronic Acid, CAS: /, stock: 1.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₃BN₃O₃.

(5-Amino-6-methoxypyrazin-2-yl)boronic Acid, CAS: 1161497-38-6, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈BN₃O₃.

(E)-3-Penten-1-yne, CAS: 2004-69-5, stock: 6.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆.

1-(2-Amino-3,4,5-trimethoxyphenyl)-ethanone, CAS: 42465-69-0, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₄.

1-Methyl-1H-benzimidazol-5-ol, CAS: 50591-22-5, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O.

1H-Pyrazole-4-boronic Acid, CAS: 763120-58-7, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅BN₂O₂.

2,3-Dihydro-2-thioxo-5H-1,3,4-thiadiazolo[2,3-b]quinazolin-5-one, CAS: 106511-81-3, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅N₃OS₂.

2,3-Dihydro-2-[3-(2-phenoxyethoxy)phenyl]-4(1H)-quinazolinone-D5, CAS: /, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅D₅N₂O₃.

2,5-Dichloro-4-Pyridinemethanol, CAS: 866039-42-1, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅Cl₂NO.

2,8-Dichloro-4(3H)-quinazolinone, CAS: 62484-39-3, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄Cl₂N₂O.

2-Amino-5,6,7,8-tetrahydro-1H-quinazolin-4-one, CAS: 33081-07-1, stock: 1.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O.

2-Amino-5-(4-methoxyphenyl)-1,3,4-thiadiazole, CAS: 1014-25-1, stock: 9.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₃OS.

2-Amino-7,8-dihydro-7,7-dimethyl-4-propyl-5(6H)quinazolinone, CAS: 331966-05-3, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉N₃O.

2-​Chloro-​6,​7-​dimethoxy-​3H-​quinazolin-​4-​one, CAS: 20197-86-8, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉ClN₂O₃.

2-Chloro-N-phenylacetamide, CAS: 587-65-5, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO.

2-Ethoxy-5-(tributylstannyl)pyrimidine, CAS: 1025746-10-4, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄N₂OSn.

2-Ethyl-2-methyl-2,3-dihydro-4(1H)-quinazolinone, CAS: 1012-59-5, stock: 1.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O.

2-Methyl-4(3H)-quinazolinone, CAS: 1769-24-0, stock: 5.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O.

3-(3-Methoxyphenyl)-2-thioxo-2,3-dihydro-4(1H)-quinazolinone, CAS: 56671-19-3, stock: 7.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂O₂S.

3-(Phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]-4(3H)-quinazolinone, CAS: 1290541-46-6, stock: 9.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇N₃O.

3-Amino-2,3-dihydro-2-thioxo-4(1H)-quinazolinone, CAS: 16951-33-0, stock: 3.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃OS.

3-Amino-4(3H)-quinazolinone, CAS: 14663-46-8, stock: 8.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃O.

3-Chloro-2-(trifluoromethyl)pyridine, CAS: 749875-32-9, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃ClF₃N.

3-Ethyl-2-thioxo-2,3-dihydro-4(1H)-quinazolinone, CAS: 13906-08-6, stock: 8.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂OS.

3-Isobutyl-2-thioxo-2,3-dihydro-4(1H)-quinazolinone, CAS: 117038-39-8, stock: 4.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂OS.

3-Morpholinopropylamine, CAS: 123-00-2, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂O.

4-Acetamidocyclohexanol-d10, CAS: 1241045-79-3, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₁₀NO₂.

4-Amino-5-chloropyrimidine, CAS: 101257-82-3, stock: 9.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄ClN₃.

4-Bromo-2,6-dinitroaniline, CAS: 62554-90-9, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₃O₄Br.

4-Hydroxy-7-methoxyquinazolin-6-yl Ester Acetic Acid, CAS: 179688-53-0, stock: 3.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₂O₄.

4-Hydroxyquinazoline, CAS: 491-36-1, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₂O.

5,6,7,8-Tetrahydro-2,6-naphthyridin-1-amine, CAS: 601515-40-6, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃.

5,6,7,8-Tetrahydro-5-methyl-[1]benzothieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, CAS: 76872-77-0, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₂S.

5,7-Difluoro-4(3H)-quinazolinone, CAS: 379228-58-7, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄F₂N₂O.

5-Amino-2-chloroquinazolin-4(1H)-one, CAS: 1592996-39-8, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆ClN₃O.

5-Methyl-3-phenyl-2-thioxo-2,3-dihydro-4(1H)-quinazolinone, CAS: 117106-06-6, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂OS.

6,7-Diethoxy-4(1H)-quinazolinone,, CAS: 179246-15-2, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₃.

6,7-Dihydro-spiro[[1]benzothieno[2,3-d]pyrimidine-8(5H),2’-[1,3]dithiolane]-2,4(1H,3H)-dione, CAS: 91421-28-2, stock: 8.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O₂S₃.

6-(Bromomethyl)-2-methyl-4(3H)-quinazolinone, CAS: 112888-43-4, stock: 8.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrN₂O.

6-Amino-3H-quinazolin-4-one, CAS: 17329-31-6, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃O.

6-​Iodo-​2-​propoxy-​3-​propylquinazolin-​4(3H)​-​one, CAS: 189278-12-4, stock: 4.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇IN₂O₂.

6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one, CAS: 109229-22-3, stock: 4.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃O.

6-Chloro-1-methyl-4-phenyl-2(1H)-quinazolinone, CAS: 20927-53-1, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁ClN₂O.

6-Chloro-4-hydroxy-2-methylquinazoline, CAS: 08/09/7142, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇ClN₂O.

6-Hydroxy-7-methoxy-4(1H)-quinazolinone, CAS: 179688-52-9, stock: 4.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O₃.

6-Nitro-4-quinazolone, CAS: 6943-17-5, stock: 9.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅N₃O₃.

7,8,9,10-Tetrahydro-benzo[f]quinazoline-1,3(2H,4H)-dione, CAS: 103494-98-0, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O₂.

7-(3-Hydroxypropoxy)-4(3H)-quinazolinone, CAS: 557770-89-5, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₃.

7-Fluoro-4(3H)-quinazolinone, CAS: 16499-57-3, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅FN₂O.

7-Hydroxy-6-methoxy-3,4-dihydroquinazolin-4-one, CAS: 162012-72-8, stock: 3.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O₃.

7-Methoxy-3-methyl-6-[2-(quinolin-2-yl)ethoxy]quinazolin-4(3H)-one, CAS: 1006891-07-1, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉N₃O₃.

8,9-Dihydro-spiro[7H-cyclopenta[f]quinazoline-7,2’-[1,3]dithiolane]-1,3(2H,4H)-dione, CAS: 103494-99-1, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₂O₂S₂.

8-Bromo-4(1h)-quinazolinone, CAS: 77150-35-7, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrN₂O.

8-Hydroxy-2-methyl-4(3H)-quinazolinone, CAS: 90417-38-2, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O₂.

8-Methoxy-2-methyl-4(3H)-quinazolinone, CAS: 90915-45-0, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂O₂.

9,10-Dihydro-spiro[benzo[f]quinazoline-7(2H),2’-[1,3]dithiolane]-1,3(4H,8H)-dione, CAS: /, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O₂S₂.

Afloqualone, CAS: 56287-74-2, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄FN₃O.

Albaconazole, CAS: 187949-02-6, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆ClF₂N₅O₂.

Albaconazole-d3, CAS: 1217825-34-7, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃D₃ClF₂N₅O₂.

Altanserin Hydrochloride, CAS: 1135280-78-2, stock: 7.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂FN₃O₂S • HCl.

CAL-101 N-β-D-Glucuronide, CAS: /, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₆FN₇O₇.

CAL-101-d5, CAS: /, stock: 7.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₃D₅FN₇O.

cis-4-Aminocyclohexanecarboxylic Acid, CAS: 3685-23-2, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₂.

CP-10447, CAS: 843-93-6, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃BrN₂O.

Dimethylnasetron, CAS: 863774-58-7, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₂S.

Didesethyl Quinagolide Hydrochloride, CAS: /, stock: 8.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆ClN₃O₃S.

DPC 083, CAS: 214287-99-7, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂ClF₃NO.

DPC 083-d4, CAS: /, stock: 10g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈D₄ClF₃N₂O.

Didesethyl Quinagolide-d7 Hydrochloride, CAS: /, stock: 2.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₇ClN₃O₃S.

N-Desethyl Quinagolide Hydrochloride, CAS: 1049775-69-0, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₀ClN₃O₃S.

(+)-Dihydroquinidine, CAS: 1435-55-8, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₂O₂.

DPC 961, CAS: 214287-88-4, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀ClF₃N₂O.

DPC 961-d4, CAS: /, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₆D₄ClF₃N₂O.

N-Desethyl Quinagolide-d5 Hydrochloride, CAS: /, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅D₅ClN₃O₃S.

Quinagolide Hydrochloride, CAS: 94424-50-7, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄ClN₃O₃S.

(3R)-Hydroxyquinidine, CAS: 60761-51-5, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₃.

(3R)-Hydroxyquinidine-vinyl-d3, CAS: 1267650-60-1, stock: 8.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃N₂O₃.

Erastin, CAS: 571203-78-6, stock: 3.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁ClN₄O₄.

Quinagolide-d10 Hydrochloride, CAS: 2124271-77-6, stock: 9.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄D₁₀ClN₃O₃S.

(3S)-3-Hydroxy Quinidine, CAS: 53467-23-5, stock: 1.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₃.

(3S)-3-Hydroxy Quinidine-vinyl-d3, CAS: /, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃N₂O₃.

Ethyl cis-4-Aminocyclohexanecarboxylate Hydrochloride, CAS: 61367-17-7, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈ClNO₂.

(3S,4R)-4-Amino-3-fluoropiperidine-1-carboxylic Acid tert-Butyl Ester, CAS: 907544-20-1, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉FN₂O₂.

Fenquizone, CAS: 20287-37-0, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂ClN₃O₃S.

Fenquizone-D5, CAS: /, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₇D₅ClN₃O₃S.

(R)-4’-Hydroxy Warfarin, CAS: 63740-78-3, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₅.

(S)-4’-Hydroxy Warfarin, CAS: 68407-05-6, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₅.

Glycolic Anhydride Diacetate, CAS: 25769-61-3, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₇.

(S)-7-Benzyloxy Warfarin Quinidine Salt, CAS: /, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₄₆N₂O₇.

2’-Quinidinone (Mixture of Diastereomers), CAS: /, stock: 8.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₂.

9-Acetoxy Rubanone, CAS: 60723-43-5, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₄.

1-(Dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol, CAS: 62265-67-2, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁Cl₂NO₂.

Quinfamide, CAS: 62265-68-3, stock: 8.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃Cl₂NO₄.

IC 87114, CAS: 371242-69-2, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉N₇O.

β-oxo-Cyclohexanepropanenitrile, CAS: 62455-70-3, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NO.

9-epi-Quinidine, CAS: 572-59-8, stock: 2.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₂.

LY 225910, CAS: 133040-77-4, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₄BrN₃O₂.

Mdivi-1, CAS: 338967-87-6, stock: 8.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀Cl₂N₂O₂S.

Cinchonidine, CAS: 485-71-2, stock: 2.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O.

Dextromethorphan Hydrobromide, CAS: 125-69-9, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅NO  • HBr.

Mebroqualone, CAS: 4260-20-2, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁BrN₂O.

O-Desmethyl Quinidine, CAS: 70877-75-7, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O₂.

O-Desmethyl Quinine, CAS: 524-63-0, stock: 6.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O₂.

O-Desmethyl Quinine Hydrobromide, CAS: /, stock: 2.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O₂ • HBr.

Quinidine, CAS: 56-54-2, stock: 7.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₂.

Quinidine 1’-Oxide, CAS: 115730-97-7, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₃.

Methyl 6-Methylpyridine-2-carboxylate, CAS: 13602-11-4, stock: 2.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

Quinidine Hydrochloride Dihydrate, CAS: 6119-47-7, stock: 9.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅ClN₂O₂•2[H₂O].

Metolazone, CAS: 17560-51-9, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆ClN₃O₃S.

Metolazone-d7, CAS: /, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₉D₇ClN₃O₃S.

Quinidine Methiodide, CAS: 42982-87-6, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇IN₂O₂.

Quinidine Methiodide-d3, CAS: /, stock: 7.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄D₃IN₂O₂.

NKY 80, CAS: 299442-43-6, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁N₃O₂.

Quinidine N-Oxide, CAS: 70116-00-6, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₃.

Quinidine Sulfate, CAS: 747-45-5, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₂ .H₂SO₄.

Nolatrexed Dihydrochloride, CAS: 152946-68-4, stock: 3.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄Cl₂N₄OS.

Nolatrexed-d4 Dihydrochloride, CAS: 1246815-52-0, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀D₄Cl₂N₄OS.

Quinidine sulfate dihydrate, CAS: 6591-63-5, stock: 6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₈N₄O₄ • H ₂O₄S • 2H  ₂O.

Quinidine-d3, CAS: 1267657-68-0, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃N₂O₂.

Oxalic Acid Ethyl Ester, CAS: 617-37-8, stock: 3.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O₄.

PIK-293, CAS: 900185-01-5, stock: 2.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉N₇O.

Quinidine-d3 1’-Oxide, CAS: /, stock: 2.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃N₂O₃.

Quinidine-d3 N-Oxide, CAS: /, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃N₂O₃.

PIK-293-d7, CAS: /, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₂D₇N₇O.

Quinine, CAS: 130-95-0, stock: 2.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₂.

Quinine Sulfate Dihydrate, CAS: 6119-70-6, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₄N₄O₁₀S.

PIK-294, CAS: 900185-02-6, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₃N₇O₂.

PIK-294-d7, CAS: /, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₆D₇N₇O₂.

Quinine-d3, CAS: /, stock: 4.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃N₂O₂.

1,2-Bis[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethane, CAS: 1371638-05-9, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₄N₆O₂S₂.

Proquazone, CAS: 22760-18-5, stock: 9.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₂O.

Qc 1, CAS: 403718-45-6, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₆F₃N₃O₂S.

1,2-Bis[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethane-d16, CAS: /, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₂₈D₁₆N₆O₂S₂.

1,3-Dichloro-2-nitrobenzene, CAS: 601-88-7, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Cl₂NO₂.

Quinethazone, CAS: 73-49-4, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂ClN₃O₃S.

Quinethazone-d5, CAS: 1794737-41-9, stock: 7.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇D₅ClN₃O₃S.

rac-Febrifugine Dihydrochloride, CAS: 32434-42-7, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁C₂lN₃O₃.

Retro-2, CAS: 1429192-00-6, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆N₂OS.

RVX 208, CAS: 1044870-39-4, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₅.

11-(4-(2-(2-(2-Chloroethoxy)ethoxy)ethyl)piperazin-1-yl)dibenzo[b,f][1,4]thiazepine, CAS: /, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈ClN₃O₂S.

11-(4-Ethyl-1-piperazinyl)-dibenzo[b,f][1,4]thiazepine Dihydrochloride, CAS: /, stock: 5.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃Cl₂N₃S.

RVX 208-d4, CAS: /, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈D₄N₂O₅.

11-(4-Methyl-1-piperazinyl)dibenzo[b,f][1,4]thiazepine, CAS: 09/09/1977, stock: 3.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₃S.

11-​[4-​[2-​[2-​(2-​Chloroethoxy)​ethoxy]​ethyl]​-​1-​piperazinyl]​-dibenzo[b,​f]​[1,​4]​thiazepine, CAS: 2206607-05-6, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈ClN₃O₂S.

YIL 781, CAS: 875258-85-8, stock: 9.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈FN₃O₂.

11-Ethoxydibenzo[b,f][1,4]thiazepine, CAS: /, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NOS.

11-Methoxydibenzo[b,f][1,4]thiazepine, CAS: /, stock: 9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NOS.

2-(2-(4-(2-Hydroxyethyl)piperazin-1-yl)ethoxy)ethyl Acetate, CAS: /, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₄.

2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethyl Acetate, CAS: 844639-07-2, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇N₃O₃S.

2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl-d8)ethoxy)ethyl Acetate, CAS: /, stock: 3.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉D₈N₃O₃S.

2-​[(2-​Aminophenyl)​sulfanyl]​benzonitrile, CAS: 140425-65-6, stock: 2.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₂S.

2-(2,2-Diphenyl-1,3-benzodioxol-5-yl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one, CAS: 357194-03-7, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₈O₇.

2-(2,2-Diphenyl-1,3-benzodioxol-5-yl)-3,5,7-tris(phenylmethoxy)-4H-1-benzopyran-4-one, CAS: 498548-14-4, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₃₆O₇.

2-Nitro-1,3-bis(phenylthio)benzene, CAS: 98119-89-2, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₃NO₂S₂.

2-(2,2-Diphenyl-1,3-benzodioxol-5-yl)-5,7-dihydroxy-3-(phenylmethoxy)-4H-1-benzopyran-4-one, CAS: 498548-17-7, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₂₄O₇.

2-(2,2-Diphenyl-1,3-benzodioxol-5-yl)-5-hydroxy-3,7-bis(phenylmethoxy)-4H-1-benzopyran-4-one, CAS: /, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₃₀O₇.

2-[2-(1-Piperazinyl)ethoxy]ethanol 1-Acetate, CAS: 936094-62-1, stock: 7.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₃.

2-(2,2-Diphenyl-1,3-benzodioxol-5-yl)-5-hydroxy-3-phenylmethoxy-4H-1-benzopyran-4-one 7-O-β-D-Glucuronide, CAS: /, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₂O₁₃.

2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethyl Ester 2-Chloro-acetic Acid, CAS: 1798840-32-0, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆ClN₃O₃S.

2-[2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethoxy]ethanol Fumarate, CAS: 1356906-16-5, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃N₃O₇S.

2-[2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethoxy]ethanol-d8 Fumarate, CAS: /, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₅D₈N₃O₇S.

2-[2-[2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethoxy]ethoxy]-ethanol Fumarate, CAS: /, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₇N₃O₈S.

2-[2-[2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethoxy]ethoxy]-ethanol-d8 Fumarate, CAS: /, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₉D₈N₃O₈S.

3’,4’,7-Tri-O-benzylquercetin, CAS: 183067-65-4, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₂₈O₇.

2-[2-[2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethoxy]ethoxy]ethanol, CAS: 1356906-17-6, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃N₃O₄S.

4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-(2-(2-hydroxyethoxy)ethyl)-1-(2-hydroxyethyl)piperazin-1-ium, CAS: /, stock: 9.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀N₃O₃S.

6-O-α-D-Glucosyl-β-cyclodextrin, CAS: 92517-02-7, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₈₀O₄₀.

6-O-α-D-Maltosyl-β-cyclodextrin, CAS: 104723-60-6, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₉₀O₄₅.

7-Benzyloxy Quetiapine, CAS: 329217-58-5, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁N₃O₃S.

7-Benzyloxy-N-des[[2-(2-hydroxy)ethoxy]ethyl] Quetiapine, CAS: 1076198-97-4, stock: 8.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃N₃OS.

3’-O-Methyl Quercetin 3-O-β-D-Glucuronide, CAS: 36687-76-0, stock: 7.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀O₁₃.

3’-O-Methyl Quercetin 3-O-β-D-Glucuronide-d3, CAS: /, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇D₃O₁₃.

7-Benzyloxy-N-des[[2-(2-hydroxy)ethoxy]ethyl] Quetiapine-d8, CAS: 1185177-12-1, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₅D₈N₃OS.

7-Hydroxy Quetiapine, CAS: 139079-39-3, stock: 1.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₃O₃S.

(o-Nitrophenyl)pyruvic Acid 2-Oxime, CAS: 27878-36-0, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O₅.

7-Hydroxy Quetiapine (1.0 mg/mL in Methanol), CAS: 139079-39-3, stock: 1.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₃O₃S.

7-Hydroxy Quetiapine Acetate, CAS: 329217-62-1, stock: 8.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇N₃O₄S.

7-Hydroxy Quetiapine S-Oxide, CAS: 1185170-04-0, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₃O₄S.

7-Hydroxy Quetiapine-d8, CAS: 1185098-57-0, stock: 7.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇D₈N₃O₃S.

7-Hydroxy-N-des{[2-(2-hydroxy)ethoxy]ethyl} Quetiapine Dihydrochloride, CAS: 1397181-83-7, stock: 3.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉Cl₂N₃OS.

7-Hydroxy-N-des{[2-(2-hydroxy)ethoxy]ethyl} Quetiapine-d8 Dihydrochloride, CAS: /, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₁D₈Cl₂N₃OS.

7-O-Benzyloxy Quetiapine-d8, CAS: /, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₃D₈N₃O₃S.

9,11-Dichloro-dibenzo[b,f][1,4]thiazepine, CAS: 1798293-05-6, stock: 1.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₇Cl₂NS.

9-(Dibenzo[b,f][1,4]thiazepin-11-yl)-3-oxa-6,9-diazaspiro[5.5]undecan-6-ium Chloride, CAS: /, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄ClN₃OS.

9-Chloro Quetiapine, CAS: 1371638-11-7, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄ClN₃O₂S.

9-Chloro Quetiapine-D8, CAS: /, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆D₈ClN₃O₂S.

9-Chloro-dibenzo[b,f][1,4]thiazepin-11(10H)-one, CAS: 1798293-04-5, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈ClNOS.

3-Fluoropyruvic Acid, CAS: 433-48-7, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃FO₃.

Di(2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl))-2-propoxyethyl Propionate, CAS: 1798840-31-9, stock: 8.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₂N₆O₃S₂.

Di(2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl))-2-propoxyethyl Propionate-d8, CAS: /, stock: 1.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₄D₈N₆O₃S₂.

3-Hydroxypyruvic Acid-13C2, CAS: 131000-16-3, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₂H₄O₄.

Narcissoside, CAS: 604-80-8, stock: 6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂O₁₆.

Narcissoside-d3, CAS: /, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉D₃O₁₆.

Dibenzo[b,f][1,4]thiazepine-11-[10H]one, CAS: 07/07/3159, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉NOS.

Ethyl Quetiapine Fumarate Salt, CAS: /, stock: 9.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃N₃O₆S.

3-Phosphono Pyruvic Acid Cyclohexylamine Salt, CAS: /, stock: 7.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅O₆P x C₆H₁₃N.

Ethyl Quetiapine-d5, CAS: /, stock: 1.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄D₅N₃O₂S.

Quercetin, CAS: 17-39-5, stock: 2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀O₇.

N,N’-Bis[2-(phenylthio)phenyl]urea, CAS: 102893-57-2, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₀N₂OS₂.

Quercetin 3,3’,4’,5-Tetraacetate, CAS: 143631-95-2, stock: 1.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈O₁₁.

Bromopyruvic Acid, CAS: 1113-59-3, stock: 1.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃BrO₃.

N-(2-(Phenylthio)phenyl)dibenzo[b,f][1,4]thiazepin-11-amine, CAS: /, stock: 8.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₈N₂S₂.

N-Des-3-oxa-5-hydroxypentyl N-(4-(3-Oxa-5-hydroxypentyl)piperazin-1-yl)ethyl Quetiapine, CAS: /, stock: 8.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇N₅O₂S.

Quercetin 3-O-β-D-Glucuronide, CAS: 22688-79-5, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈O₁₃.

N-Des[2-(2-hydroxyethoxy)ethyl] N-[4-(N-Methylamino)butylcarboxy] Quetiapine Hydrochloride, CAS: /, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇ClN₄OS.

Quercetin 3-O-β-Gentiobioside, CAS: 7431-83-6, stock: 7.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀O₁₇.

N-Des[2-(2-hydroxyethoxy)ethyl] Quetiapine Dihydrochloride, CAS: 111974-74-4, stock: 3.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉Cl₂N₃S.

N-Des[2-(2-hydroxyethoxy)ethyl] Quetiapine Dihydrochloride (1.0 mg/mL in Methanol), CAS: 111974-74-4, stock: 7.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉Cl₂N₃S.

Hydroxypyruvic Acid Phosphate Barium Salt (>90%), CAS: 114887-36-4, stock: 1.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅O₇P•3/2Ba.

Quercetin 3-Sulfate Potassium Salt, CAS: /, stock: 7.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀O₁₀S xK.

N-Des[2-(2-hydroxyethoxy)ethyl] Quetiapine-d4 Dihydrochloride, CAS: /, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₄Cl₂N₃S.

N-Des[2-(2-hydroxyethoxy)ethyl] Quetiapine-d8, CAS: 1189866-35-0, stock: 4.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₉D₈N₃S.

Quercetin 4’-Glucoside, CAS: 20229-56-5, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₁₂.

N-Des[2-(2-hydroxyethoxy)ethyl]-N-pheyloxycarbonyl Quetiapine, CAS: /, stock: 6.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁N₃O₂S.

β-Hydroxypyruvic Acid, CAS: 1113-60-6, stock: 8.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄O₄.

Quercetin 4’-Glucoside-d3, CAS: /, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇D₃O₁₂.

Quercetin 7-O-β-D-Glucuronide, CAS: 38934-20-2, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈O₁₃.

Quercetin 7-O-β-D-Glucuronide 3-Sulfate Disodium Salt, CAS: /, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆Na₂O₁₆S.

O-Dibenzo[b,f][1,4]thiazepinyl Quetiapine, CAS: 1800608-95-0, stock: 2.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₂N₄O₂S₂.

O-Dibenzo[b,f][1,4]thiazepinyl Quetiapine-D8, CAS: /, stock: 10g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₄D₈N₄O₂S.

Phosphoenolpyruvic Acid tris(Cyclohexylammonium) Salt, CAS: 35556-70-8, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅O₆P.₃[C₆H₁₃N].

Pyruvic Acid Ethyl Ester, CAS: 617-35-6, stock: 9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₃.

Quercetin-3-O-Sophoroside, CAS: 18609-17-1, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀O₁₇.

O-Triphenylmethoxy Quetiapine, CAS: 844639-06-1, stock: 7.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₉N₃O₂S.

Pyruvic Acid Sodium Salt-13C2, CAS: 89196-78-1, stock: 2.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₂H₃NaO₃.

Pyruvic Acid-13C Ethyl Ester, CAS: 905440-74-6, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₈O₃.

Quercetol 3-Glucoside 7-Rhamnoside, CAS: 18016-58-5, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀O₁₆.

O-Triphenylmethoxy Quetiapine-D8, CAS: /, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₁D₈N₃O₂S.

Phenyl[2-phenylthio)phenyl]carbamate, CAS: 111974-73-3, stock: 3.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅NO₂S.

[5,7-Diacetyloxy-2-(3,4-diacetyloxyphenyl)-4-oxochromen-3-yl] Acetate, CAS: 1064-06-8, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₀O₁₂.

Quetiapine, CAS: 111974-69-7, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₃O₂S.

Pyruvonitrile, CAS: 631-57-2, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃NO.

Sodium Mercaptopyruvate, CAS: 10255-67-1, stock: 2.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃NaO₃S.

Sulfopyruvic Acid Dilithium Salt, CAS: 103963-67-3, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄Li₂O₆S.

Quetiapine Hemifumarate, CAS: 111974-72-2, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₄N₆O₈S₂.

tert-Butyl 3-Bromo-2-oxopropanoate, CAS: 16754-73-7, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁BrO₃.

Quetiapine Impurity-N, CAS: 1800291-86-4, stock: 5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₁N₅O₃S.

Quetiapine N-Oxide, CAS: 1076199-40-0, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₃O₃S.

Quetiapine Sulfone, CAS: 329216-65-1, stock: 9.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₃O₄S.

Quetiapine Sulfone-d8, CAS: /, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇D₈N₃O₄S.

Quetiapine Sulfoxide, CAS: 329216-63-9, stock: 2.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₃O₃S.

Quetiapine Sulfoxide-d8, CAS: 1330238-38-4, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇D₈N₃O₃S.

Quetiapine-d4 Fumarate, CAS: 1331636-50-0, stock: 6.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅D₄N₃O₆S.

Quetiapine-d4 Hemifumarate, CAS: 1217310-65-0, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₄N₃O₂S  •1/2C₄H₄O₄.

Quetiapine-d8 Fumarate, CAS: 1185247-12-4, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₁D₈N₃O₆S.

Quetiapine-d8 Hemifumarate, CAS: 1031703-36-2, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇D₈N₃O₂S  •1/2C₄H₄O₄.

(-)-Thysanone, CAS: 233279-24-8, stock: 3.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₆.

1,2-Chrysenedione, CAS: 2304-83-8, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀O₂.

1,4,5,8-Tetrahydroxyanthra-9,10-quinone, CAS: 81-60-7, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈O₆.

1,4-Chrysenequinone, CAS: 100900-16-1, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀O₂.

2,2’-Dibromodiethylamine Hydrobromide, CAS: 43204-63-3, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀Br₃N.

2,3-Bis(10-bromodecyl)-5,6-dimethylcyclohexa-2,5-diene-1,4-dione, CAS: /, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆Br₂O₂.

2,3-Bis(10-chlorodecyl)-5,6-dimethylcyclohexa-2,5-diene-1,4-dione, CAS: /, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆Cl₂O₂.

2,6-Bis(1,1-dimethylethyl)-4-ethylidene-2,5-cyclohexadien-1-one, CAS: 6738-27-8, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄O.

2-(4-((5,6-Dimethoxyquinolin-8-yl)amino)pentyl)isoindoline-1,3-dione, CAS: /, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅N₃O₄.

2-(4-((5,6-Dimethoxyquinolin-8-yl)amino)pentyl)isoindoline-1,3-dione-d6, CAS: /, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉D₆N₃O₄.

2-Amino-5-(hydroxymethyl)thiazole, CAS: 131184-73-1, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₂OS.

2-​Chloro-​2-​oxo-ethanethioic Acid S-Phenyl Ester, CAS: 215245-36-6, stock: 6.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅ClO₂S.

2-Iodotoluene, CAS: 615-37-2, stock: 2.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇I.

2-Thenoyltrifluoroacetone, CAS: 326-91-0, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅F₃O₂S.

2-[(2-Hydroxyethyl)thio]-3-methyl-1,4-napthalenedione, CAS: 59147-84-1, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂O₃S.

3,8-Dimethylacenaphthenequinone, CAS: 146885-81-6, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₂.

3-Aminobenzyl Alcohol, CAS: 1877-77-6, stock: 1.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉NO.

4,5-Dimorpholin-4-ylbenzo-1,2-quinone, CAS: 4608-10-0, stock: 4.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₄.

4-Fluoroquinoline, CAS: 394-70-7, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆FN.

5,6-Dimethoxy-8-quinolinamine, CAS: 09/02/6938, stock: 9.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₂.

5,6-Orthoquinone Primaquine Dihydrobromide, CAS: /, stock: 7.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O₂  • 2HBr.

5,6-Orthoquinone Primaquine-d6 Hydrobromide (~85%), CAS: /, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁D₆N₃O₂ • x( HBr).

5,​6-​Chrysenedione, CAS: 07/10/2051, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀O₂.

5-(10-Bromodecyl)-2,3-dimethyl-2,5-cyclohexadiene-1,4-dione, CAS: 128209-65-4, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇BrO₂.

5-(10-Chlorodecyl)-2,3-dimethylbenzene-1,4-diol, CAS: /, stock: 7.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉ClO₂.

5-(10-Chlorodecyl)-2,3-dimethylcyclohexa-2,5-diene-1,4-dione, CAS: /, stock: 5.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇ClO₂.

5-Hydroxyquinoxaline, CAS: 17056-99-4, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₂O.

5-Methoxyprimaquine, CAS: 47136-26-5, stock: 5.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₃O₂.

5-Methoxyprimaquine-d6, CAS: /, stock: 5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇D₆N₃O₂.

6,13-Pentacenedione-d12, CAS: 68234-48-0, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂D₁₂O₂.

6,13-Pentacenequinone, CAS: 3029-32-1, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₂O₂.

6-Hydroxydopaquinone, CAS: 135791-48-9, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₅.

9-(2-Carboxyphenyl)-3,6-bis(ethylamino)-2,7-dimethylxanthylium Cesium Salt, CAS: 1254945-67-9, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇CsN₂O₃.

9-[2-[[[10-(4,5-Dimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)decyl]oxy]carbonyl]phenyl]-3,6-bis(ethylamino)-2,7-dimethyl-Xanthylium, CAS: 1097639-76-3, stock: 2.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₅₃N₂O₅.

Alloxazine, CAS: 490-59-5, stock: 3.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₄O₂.

Benzo[a]pyrene-4,5-quinone, CAS: 42286-46-4, stock: 1.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₀O₂.

Benzo[a]pyrene-9,10-dione, CAS: 82120-25-0, stock: 1.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₀O₂.

beta-Rubromycin, CAS: 27267-70-5, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₀O₁₂.

Blattellaquinone, CAS: 849762-24-9, stock: 5.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₄.

Bovine COQ3 (Ubiquinone biosynthesis O-methyltransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine DHODH (Dihydroorotate dehydrogenase (quinone), mitochondrial) ELISA Kit (96T), CAS: /, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine NDUFA10 (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial) ELISA Kit (96T), CAS: /, stock: 6.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Cochlioquinone B, CAS: 32450-26-3, stock: 4.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₀O₆.

Deoxynyboquinone, CAS: 96748-86-6, stock: 1.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂O₄.

Desacetyl Rifampicin Quinone, CAS: 65110-92-1, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₅₄N₄O₁₁.

Diclofenac 2,5-Quinone Imine, CAS: 1254576-93-6, stock: 2.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉Cl₂NO₃.

Dimethyl cis-1,2-Cyclopropanedicarboxylate, CAS: 826-34-6, stock: 4.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀O₄.

Dopaquinone Lactone, CAS: 255829-51-7, stock: 6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO₄.

Dunnione, CAS: 33404-57-8, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₃.

Geranyl Bromide (>80%), CAS: 6138-90-5, stock: 9.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇Br.

Heptaprenyl Diphosphate-1,2,3,4-13C4, CAS: /, stock: 5.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁¹³C₄H₆₀O₇P₂.

Human COQ3 (Ubiquinone biosynthesis O-methyltransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 9.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CYP4F2 (Phylloquinone omega-hydroxylase CYP4F2) ELISA Kit (96T), CAS: /, stock: 6.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human ETFDH(Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human NDUFA10 (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial) ELISA Kit (96T), CAS: /, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human NDUFA6(NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6) ELISA Kit (96T), CAS: /, stock: 1.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human NQO1(NAD(P)H dehydrogenase [quinone] 1) ELISA Kit (96T), CAS: /, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Ilimaquinone, CAS: 71678-03-0, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀O₄.

Isoliquiritigenin, CAS: 961-29-5, stock: 7.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O₄.

α-Lapachone, CAS: 4707-33-9, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₃.

β-Lapachone (90%), CAS: 4707-32-8, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₃.

Karminomycin Hydrochloride, CAS: 52794-97-5, stock: 3.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇NO₁₀ • (HCl).

Mouse Coq3 (Ubiquinone biosynthesis O-methyltransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Dhodh (Dihydroorotate dehydrogenase (quinone), mitochondrial) ELISA Kit (96T), CAS: /, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Ndufa10 (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial) ELISA Kit (96T), CAS: /, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Nqo2 (Ribosyldihydronicotinamide dehydrogenase [quinone]) ELISA Kit (96T), CAS: /, stock: 7.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Sqrdl (Sulfide:quinone oxidoreductase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

N-(3,4-Dimethoxyphenyl)acetamide, CAS: 881-70-9, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃.

N-(4,5-Dimethoxy-2-nitrophenyl)acetamide, CAS: 99069-17-7, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₅.

Polyketomycin, CAS: 200625-47-4, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₈O₁₈.

Rat Coq3 (Ubiquinone biosynthesis O-methyltransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Dhodh (Dihydroorotate dehydrogenase (quinone), mitochondrial) ELISA Kit (96T), CAS: /, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Ndufa10 (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial) ELISA Kit (96T), CAS: /, stock: 5.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat NQO1(NAD(P)H dehydrogenase [quinone] 1) ELISA Kit (96T), CAS: /, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Nqo2 (Ribosyldihydronicotinamide dehydrogenase [quinone]) ELISA Kit (96T), CAS: /, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rifampicin Quinone, CAS: 13983-13-6, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₆N₄O₁₂.

SkQR1, CAS: 1333381-77-3, stock: 4.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₅₆N₂O₆.

Tetra-tert-butyldiphenoquinone, CAS: 2455-14-3, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₀O₂.

Thionaphthenquinone, CAS: 493-57-2, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₂S.

Vitamin K1 2,3-Epoxide, CAS: 1588773-08-3, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₆O₃.

Vitamin K1-d7 2,3-Epoxide, CAS: 1795136-97-8, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₉D₇O₃.

W-15, CAS: 93100-99-3, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁ClN₂O₂S.

W-15-d4, CAS: /, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇D₄ClN₂O₂S.

Xanthomegnin, CAS: 1685-91-2, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₂O₁₂.

[10-(2,5-Dihydroxy-3,4-dimethylphenyl)decyl]triphenyl-phosphonium Bromide, CAS: 1146973-74-1, stock: 3.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₄BrO₂P.

[10-(2,5-Dihydroxy-3,4-dimethylphenyl)decyl]triphenyl-phosphonium Chloride, CAS: /, stock: 8.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₄ClO₂P.

α-(4-Chlorophenyl)-2-ethyl-1,3-dioxolane-2-acetonitrile, CAS: 55474-41-4, stock: 4.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄ClNO₂.

α-(4-Chlorophenyl)-α-propionylacetonitrile, CAS: 55474-40-3, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀ClNO.

Pyrimethamine, CAS: 58-14-0, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃ClN₄.

Pyrimethamine-d3, CAS: 1189936-99-9, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀D₃ClN₄.

1,2-Dimethyl-1,4,5,6-tetrahydropyrimidine, CAS: 4271-96-9, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂N₂.

Morantel Tartrate, CAS: 26155-31-7, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂N₂O₆S.

Pteroic Acid Sulfosuccinimidyl Ester, Technical Grade, CAS: /, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅N₇O₈S.

rac-5-Menthylcarbamoyl-5,6,7,8-tetrahydropteroic Acid, CAS: /, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄N₆O₅.

(+)-Chloropseudoephedrine Hydrochloride, CAS: 94133-42-3, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClN  • HCl.

(+)-Chloropseudoephedrine Hydrochloride (1.0 mg/mL in Methanol), CAS: 94133-42-3, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClN  • HCl.

(1S,2R)-(+)-Ephedrine hemisulfate, CAS: 93918-98-0, stock: 3.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  2(C₁₀H₁₅NO)  •  H₂O₄S.

(1S,2R,3S)-1-((5S,6S)-2-Hydroxy-4,5-dimethyl-6-phenylmorpholin-2-yl)butane-1,2,3,4-tetraol, CAS: /, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO₆.

(R)-2-(((1S,2S)-1-Hydroxy-1-phenylpropan-2-yl)(methyl)amino)propanoic Acid, CAS: /, stock: 1.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₃.

(S)-2-(((1S,2S)-1-Hydroxy-1-phenylpropan-2-yl)(methyl)amino)propanoic Acid, CAS: /, stock: 4.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₃.

O-Acetyl Pseudoephedrine Hydrochloride, CAS: 1630-34-8, stock: 2.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈ClNO₂.

rac O-Acetyl Pseudoephedrine Hydrochloride, CAS: 1630-34-8, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈ClNO₂.

1-(3-Methoxypropyl)-4-piperidinamine, CAS: 179474-79-4, stock: 6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀N₂O.

Prucalopride Hydroxy Impurity, CAS: /, stock: 8.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆ClN₃O₄.

Prucalopride-d5, CAS: /, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁D₅ClN₃O₃.

Prucalopride-N-β-D-cellobiose, CAS: /, stock: 6.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₆ClN₃O₁₃.

Protionamide, CAS: 14222-60-7, stock: 2.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂S.

Protionamide-d7, CAS: /, stock: 8.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅D₇N₂S.

(+)-Corey Lactone Benzoate, CAS: 53275-53-9, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆O₅.

(-)-Corey Lactone, CAS: 31752-99-5, stock: 2.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₅.

(-)-Corey Lactone Benzoate, CAS: 39746-00-4, stock: 9.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆O₅.

(16R)-Mexiprostil, CAS: 76822-56-5, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₀O₆.

(1R,2R)-rel-2-Methoxycyclopentanecarboxaldehyde, CAS: 53229-77-9, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₂.

(1S,4R)-cis-4-Acetoxy-2-cyclopenten-1-ol, CAS: 60410-16-4, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀O₃.

(2-Aminopropyl)carbamic Acid tert-Butyl Ester, CAS: 255735-88-7, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂O₂.

(3aR,4R,5R,6aS)-4-((S,E)-3-Hydroxy-5-phenylpent-1-enyl)hexahydro-2H-cyclopenta[b]furan-2,5-diol (Bimatoprost Impurity), CAS: 856240-62-5, stock: 7.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄O₄.

(3aR,4R,5R,6aS)-4-[3-(Ethyleneketal)decanyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one, CAS: 118696-65-4, stock: 3.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₂O₅.

(3aR,4R,5R,6aS)-4-[3-(Ethyleneketal)decanyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one-d15, CAS: 1217783-38-4, stock: 5.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇D₁₅O₅.

(3aR,4R,5R,6aS)-5-Hydroxy-4-((Z)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one, CAS: /, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉F₃O₅.

(3aR,4R,5R,6aS)-5-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-4-[(1E,3S)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-octen-1-yl]hexahydro-2H-cyclopenta[b]furan-2-one, CAS: 61628-05-5, stock: 4.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₂O₄Si₂.

(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2H-cyclopenta[b]furan-2-one, CAS: 26054-67-1, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O₄.

(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(3R)-3-hydroxy-5-phenylpentyl]2H-cyclopenta[b]furan-2-one, CAS: 145667-75-0, stock: 8.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄O₄.

(3aR,4S,5R,6aS)-4-(tert-Butyldimethylsilyloxy)methyl-5-hydroxy-hexahydro-2H-cyclopenta[b]furan-2-one, CAS: 65025-94-7, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆O₄Si.

(3aR,4S,5R,6aS)-4-(tert-Butyldimethylsilyloxy)methyl-5-tetrahydropyranyloxy-hexahydro-2H-cyclopenta[b]furan-2-one, CAS: 65025-95-8, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₄O₅Si.

(3aR,4S,5R,6aS)-4-(tert-Butyldiphenylsilyloxy)methyl-5-hydroxy-hexahydro-2H-cyclopenta[b]furan-2-one, CAS: 84786-80-1, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀O₄Si.

(3aR,4S,5R,6aS)-4-(tert-Butyldiphenylsilyloxy)methyl-5-tetrahydropyranyloxy-hexahydro-2H-cyclopenta[b]furan-2-one, CAS: 92596-29-7, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₈O₅Si.

(3aR,​4R,​5R,​6aS)​-Hexahydro-​5-​hydroxy-​4-​[(1E,​3R)​-​3-​hydroxy-​4-​[3-​(trifluoromethyl)​phenoxy]​-​1-​buten-​1-​yl]​-​2H-​cyclopenta[b]​furan-​2-​one, CAS: 53872-60-9, stock: 3.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉F₃O₅.

(3aS,4R,5S,6aR)-Hexahydro-5-hydroxy-4-(hydroxymethyl)-2H-cyclopenta[b]furan-2-one, CAS: 76704-05-7, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂O₄.

(5Z)-rel-Cloprostenol Sodium, CAS: 55028-72-3, stock: 1.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈ClNaO₆.

(5Z,11α,13E,15S)-11,15-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-9-oxo-prosta-5,13-dien-1-oic Acid, CAS: 85610-68-0, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₆₀O₅Si₂.

(8R,11R,12R,16RS)-Misoprostol-d5, CAS: /, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₃D₅O₅.

(R)-2-[(Diethylamino)methyl]-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-cyclopenten-1-one, CAS: 117254-07-6, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₁NO₂Si.

(S)-2-Methyl-1-(4-toluenesulfonyloxy)hexane-d3, CAS: 1329610-58-3, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉D₃O₃S.

(S)-2-Methylhexanol-d3, CAS: 1329614-76-7, stock: 10g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃D₃O.

(S)-3-Methylheptanoic Acid-d3, CAS: 1329647-33-7, stock: 7.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃D₃O₂.

(S)-Ethyl 2-(Piperidin-3-yl)acetate, CAS: 188883-58-1, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₂.

1,4-Anhydro-D-sorbitol, CAS: 27299-12-3, stock: 3.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₅.

10-​β-​D-​Glucopyranosyl-​1,​8-​dihydroxy-​3-​(hydroxymethyl)​-anthrone heptaacetate, CAS: 13928-72-8, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆O₁₆.

11-Epiprostaglandin E1, CAS: 24570-01-2, stock: 9.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₅.

13,14-Dihydro-15-keto-PGD2, CAS: 59894-07-4, stock: 8.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₅.

14-Methyl Prostaglandin E1, CAS: 41692-11-9, stock: 8.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₆O₅.

15(R)-Carboprost, CAS: 35864-81-4, stock: 5.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₆O₅.

15(S)-15-methyl Prostaglandin D2, CAS: 85280-90-6, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄O₅.

15-Deoxy-delta12,14-Prostaglandin J2, CAS: 87893-55-8, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

15-epi Prostaglandin A1, CAS: 20897-92-1, stock: 3.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂O₅.

15-epi Travoprost, CAS: 1420791-14-5, stock: 1.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅F₃O₆.

15-epi-Prostaglandin E1, CAS: 20897-91-0, stock: 2.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₅.

15-Hydroxy Lubiprostone Dicyclohexylammonium Salt, CAS: /, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₇F₂NO₅.

15-Hydroxy Lubiprostone Dicyclohexylammonium Salt-d7, CAS: /, stock: 6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₀D₇F₂NO₅.

15-keto Prostaglandin A1, CAS: 61600-67-7, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₄.

15-Keto Prostaglandin E0, CAS: 5094-14-4, stock: 9.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₅.

15-Keto Prostaglandin E0-d4, CAS: /, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀D₄O₅.

15-Keto Prostaglandin E1, CAS: 22973-19-9, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₅.

15-Keto Travoprost, CAS: 404830-45-1, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₃F₃O₆.